{
  "meta": {
    "title": "Community_Medicine_Test_-_2",
    "url": "https://brainandscalpel.vercel.app/community-medicine-test-2-92f9076a.html",
    "scrapedAt": "2025-11-30T12:49:15.752Z"
  },
  "questions": [
    {
      "text": "You are working as a medical officer in a primary health center. On 5th May 2023, you took a look at these 4 vaccine vials. Vial 1 had an expiry date of 4th May 2023 and the rest of the vials had an expiry date of 14th October 2023. Which of the following vials could be used?",
      "choices": [
        {
          "id": 1,
          "text": "Vial 4"
        },
        {
          "id": 2,
          "text": "Vial 3"
        },
        {
          "id": 3,
          "text": "Vial 2"
        },
        {
          "id": 4,
          "text": "Vial 1"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In the given scenario, only <strong>vial 2 </strong>can be used.</p>\n<p>According to the vaccine vial monitor, vial 1 and vial 2 can be used, but vial 2 is the one that was really fit for use as it had <strong>not yet expired</strong> as on 5th May 2023. Whereas, <strong>vial 1</strong> has <strong>crossed</strong> the <strong>date of expiry</strong>.</p>\n<p>Vial 3 and vial 4 should be <strong>discarded</strong> even though the drug has not expired. This is because the<strong> color</strong> in the<strong> inner square</strong> has <strong>matched</strong> the <strong>outer</strong> <strong>circle</strong> in <strong>vial 3</strong> and is <strong>darker</strong> than the outer circle in <strong>vial 4</strong>.</p>\n<p>Vaccine vial monitors (VVM) are chemical indicator labels which are used to monitor the <strong>heat stability</strong> of the vaccines and are useful throughout the vaccine supply chain. The VVMs are designed to ensure that <strong>heat-damaged vaccines</strong> are <strong>not given</strong> to the patients. They also indicate preferable order of usage of the vials, thereby minimising <strong>vaccine wastage</strong>. </p><hr><h3>Related Pearl: Vaccine Vial Monitors</h3><ul>\n<li><strong>Vaccine vial monitors</strong> are used to monitor heat exposure of vaccines.</li>\n<li>It is a chemical indicator that records the cumulative heat exposure through a gradual change in color.</li>\n<li>If the color of the <strong>inner square</strong> is the <strong>same color or darker</strong> than the <strong>outer circle</strong>, it indicates that the vaccine has been exposed to too much heat and it must be <strong>discarded</strong>.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3914a3eb19cf43ec9273112090e7b3f6x600x1199.JPEG\" alt=\"Pearl Image\"><ul>\n<li>Currently, there are <strong>four types</strong> of VVMs (VVM2, VVM7, VVM14, and VVM30). They are chosen to match the heat sensitivity of the vaccine.</li>\n<li>The VVM can be located on the label of the vaccine or on the neck or cap of the ampule/vial.</li>\n<li>VVMs also help in <strong>reduction of vaccine wastage</strong> by indicating which batch of vaccines can be used first.</li>\n</ul><hr><h3>Related Pearl: Temperature Sensitivity of Vaccines</h3><p><strong>Heat sensitivity</strong> in order of <strong>decreasing</strong> sensitivity:&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>Group</td>\n<td>Vaccines</td>\n</tr>\n<tr>\n<td>A</td>\n<td>OPV</td>\n</tr>\n<tr>\n<td>B</td>\n<td>Influenza</td>\n</tr>\n<tr>\n<td>C</td>\n<td>\n<p>IPV</p>\n<p>Japanese encephalitis(live)</p>\n<p>Measles, mumps, rubella</p>\n</td>\n</tr>\n<tr>\n<td>D</td>\n<td>\n<p>Cholera</p>\n<p>DTaP</p>\n<p>Pentavalent</p>\n<p>Rotavirus</p>\n<p>Hib(liquid)</p>\n<p>Yellow fever</p>\n<p>Measles</p>\n<p>Rubella</p>\n</td>\n</tr>\n<tr>\n<td>E</td>\n<td>\n<p>BCG</p>\n<p>HPV</p>\n<p>Japanese encephalitis(inactivated)</p>\n<p>Tetanus, TD, Td</p>\n</td>\n</tr>\n<tr>\n<td>F</td>\n<td>\n<p>Hepatitis B</p>\n<p>Hib(freeze-dried)</p>\n<p>Meningococcal A</p>\n<p>Pneumococcal</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Vaccine <strong>sensitivity to freezing</strong>:</p>\n<p><strong>Rotavirus(liquid)</strong>&lt; T,DT,dT&lt; IPV &lt; Hib(liquid)&lt; HepB &lt; Pentavalent &lt;<strong>DTaP</strong></p>\n<p>Vaccines not damaged by freezing:</p>\n<ul>\n<li>Yellow fever</li>\n<li>BCG</li>\n<li>Hib</li>\n<li>Japanese encephalitis(live and inactivated)</li>\n<li>Measles, mumps, rubella</li>\n<li>OPV</li>\n<li>Rabies</li>\n<li>Rotavirus(Freeze-dried)</li>\n<li>Varicella zoster</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c7bd80ca927b42bcb0956bc12ae146b7x956x717.PNG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/d8e38395e69c42ad9c23fcb7e5e3fb09.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6151",
      "difficulty": "medium"
    },
    {
      "text": "For a patient with pneumonic plague, you should recommend droplet precaution until:",
      "choices": [
        {
          "id": 1,
          "text": "48 hours after initiation of effective antibiotic therapy"
        },
        {
          "id": 2,
          "text": "96 hours after initiation of effective antibiotic therapy"
        },
        {
          "id": 3,
          "text": "24 hours after initiation of effective antibiotic therapy"
        },
        {
          "id": 4,
          "text": "1 week after onset of cough or fever"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Droplets precaution</strong> for a patient with <strong>pneumonic plague</strong> is recommended until <strong>48 hours after initiation of effective antibiotic therapy.</strong></p><hr><h3>Related Pearl: Period of communicability of important diseases</h3><p> </p>\n<table>\n<tbody>\n<tr>\n<td>Disease</td>\n<td>Period of communicability</td>\n</tr>\n<tr>\n<td>Chicken pox</td>\n<td> 1-2 days before to 4-5 days after appearance of rash</td>\n</tr>\n<tr>\n<td>Hepatitis B</td>\n<td>One month before the appearance of Jaundice till the disappearance of HbsAg</td>\n</tr>\n<tr>\n<td>Measles</td>\n<td>4 days before to 5 days after appearance of rash</td>\n</tr>\n<tr>\n<td>Rubella</td>\n<td>7 days before to 7 days after the rash</td>\n</tr>\n<tr>\n<td>Mumps</td>\n<td>4-6 days before to 7 days after symptoms onset</td>\n</tr>\n<tr>\n<td>Pertussis</td>\n<td>7 days before to 3 weeks after the onset of paroxysms</td>\n</tr>\n<tr>\n<td>Diphtheria</td>\n<td>Up to 4 weeks after disease onset</td>\n</tr>\n<tr>\n<td>Meningococcal meningitis</td>\n<td>Till meningococci are absent from nasal/throat swabs</td>\n</tr>\n<tr>\n<td>Influenza</td>\n<td>1 to 2 days before and 1 to 2 days after onset of symptoms</td>\n</tr>\n<tr>\n<td>Tetanus</td>\n<td>Not communicable</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n<p> </p><hr><h3>Related Pearl: Periods of Isolation for Selected Diseases</h3><p><strong class=\"ng-binding\"> Periods of Isolation for Selected Diseases</strong></p>\n<div class=\"panel-body ng-scope\">\n<p class=\"ng-binding ng-scope\"> </p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Duration of Isolation</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chickenpox</p>\n</td>\n<td>\n<p>Until all lesions are crusted – usually about 6 days after onset of rash.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Measles</p>\n</td>\n<td>\n<p>From the onset of symptoms (catarrhal stage) to 5 days after the appearance of the rash</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cholera</p>\n</td>\n<td>\n<p>Until 3 days of tetracycline therapy.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Diphtheria </p>\n</td>\n<td>\n<p>Until 48 hours of antibiotics.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Shigellosis and salmonellosis</p>\n</td>\n<td>\n<p>Until 3 consecutive negative stool cultures.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatitis A</p>\n</td>\n<td>\n<p>3 weeks.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Influenza</p>\n</td>\n<td>\n<p>3 days after onset.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Polio</p>\n</td>\n<td>\n<p>2 weeks in adult; 6 weeks in children.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tuberculosis (sputum +)</p>\n</td>\n<td>\n<p>Until 3 weeks of effective chemotherapy.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Herpes zoster</p>\n</td>\n<td>\n<p>6 days after onset of rash.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mumps</p>\n</td>\n<td>\n<p>Until the swelling subsides.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pertussis</p>\n</td>\n<td>\n<p>4 weeks or until paroxysms cease. </p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Meningococcal meningitis</p>\n</td>\n<td>\n<p>Until the first 24 hours of effective antibiotic therapy.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Streptococcal pharyngitis</p>\n</td>\n<td>\n<p>Until the first 6 hours of effective antibiotic therapy.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF6096",
      "difficulty": "medium"
    },
    {
      "text": "An insured 35-year-old man, who is working as a teacher, is undergoing a vasectomy procedure. According to the Employees State Insurance Act, he would receive the cash benefit under ____.",
      "choices": [
        {
          "id": 1,
          "text": "Enhanced sickness benefit for 7 days"
        },
        {
          "id": 2,
          "text": "Extended sickness benefit for 21 days"
        },
        {
          "id": 3,
          "text": "Enhanced sickness benefit for 14 days"
        },
        {
          "id": 4,
          "text": "Sickness Benefit for 7 days"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p class=\"ng-binding\">Insured&nbsp;persons in the productive age group undergoing sterilization procedures such as tubectomy and vasectomy are offered cash benefits under the ESI Act as&nbsp;<strong>enhanced sickness benefits.&nbsp;</strong>The enhanced sickness benefit <strong>equal to full wage</strong> is payable to insured persons undergoing sterilization for <strong>7 days</strong> for <strong>male</strong> and <strong>14 days</strong> for <strong>female</strong> workers.&nbsp;</p>\n<p class=\"ng-binding\">Other options:&nbsp;</p>\n<p class=\"ng-binding\">Option B: <strong>Extended sickness benefit</strong> is offered to insured people who are suffering from certain <strong>chronic diseases</strong>, for a maximum period of <strong>2 years</strong>, in addition to the 91 days of leave they are entitled to under the sickness benefit. During this period, they are paid about <strong>80%</strong> of the average daily wages. The insured person should have been working for a continuous period of 2 years. There are 34 listed diseases for which the extended sickness benefit can be availed.&nbsp;</p>\n<p class=\"ng-binding\">Option D:<strong> Sickness&nbsp;Benefit&nbsp;</strong>is given at<strong>&nbsp;70%&nbsp;</strong>of average daily wages for a duration of&nbsp;<strong>91 days&nbsp;</strong>in one year.&nbsp;In order to qualify for sickness benefit, the worker is required to contribute for 78 days in a period of 6 months.</p>\n</div>\n</div><hr><h3>Related Pearl: ESI ACT, 1948</h3><p><strong>Employees State Insurance Act, 1948 (Revised in 2019)</strong></p>\n<p><strong>Scope:</strong> It is applicable to all factories in India <strong>excluding</strong>:</p>\n<ul>\n<li data-listid=\"48\" data-aria-posinset=\"4\" data-aria-level=\"1\">Defence&nbsp;</li>\n<li data-listid=\"48\" data-aria-posinset=\"4\" data-aria-level=\"1\">Railway&nbsp;&nbsp;</li>\n<li data-listid=\"48\" data-aria-posinset=\"4\" data-aria-level=\"1\">Mines&nbsp;</li>\n</ul>\n<p><strong>Finance Contribution</strong></p>\n<ul>\n<li>It covers all employees getting income up to Rs.21,000/- per month.</li>\n<li data-listid=\"49\" data-aria-posinset=\"1\" data-aria-level=\"1\">Employee &ndash;<strong> 0.75%</strong> of his daily wage.</li>\n<li data-listid=\"49\" data-aria-posinset=\"2\" data-aria-level=\"1\">Employer &ndash;<strong> 3.25%</strong> of the employees' daily wage.</li>\n<li data-listid=\"49\" data-aria-posinset=\"3\" data-aria-level=\"1\">Medical benefit &ndash; 1/8th by the state government and 7/8th by the ESI Corporation.</li>\n</ul>\n<p><strong>Benefits</strong></p>\n<p><strong>To the Employees</strong></p>\n<ul>\n<li data-listid=\"50\" data-aria-posinset=\"5\" data-aria-level=\"1\"><strong>Medical</strong> Benefit- full medical care is provided free of cost in case of sickness, employment injury, and maternity.</li>\n<li data-listid=\"50\" data-aria-posinset=\"6\" data-aria-level=\"1\"><strong>Sickness</strong> Benefit- is given at <strong>70%</strong> of average daily wages for a duration of <strong>91 days</strong> in one year.&nbsp;In order to qualify for sickness benefit, the worker is required to contribute for 78 days in a period of 6 months.\n<ul>\n<li data-listid=\"51\" data-aria-posinset=\"7\" data-aria-level=\"1\"><strong>Extended</strong> sickness benefit &ndash; <strong>80%</strong> of the daily wages for a duration of<strong> 2 years,</strong> for 34 specified diseases such as TB, leprosy, malignant diseases, diabetes, Parkinson's, myasthenia gravis, glaucoma, coronary artery disease, etc.</li>\n<li data-listid=\"51\" data-aria-posinset=\"8\" data-aria-level=\"1\"><strong>Enhanced</strong> sickness benefit &ndash; at <strong>full</strong> <strong>wages</strong> for sterilization procedure; for a duration of 7 days post-vasectomy and 14 days post tubectomy.&nbsp;</li>\n<li data-listid=\"51\" data-aria-posinset=\"8\" data-aria-level=\"1\">The total amount payable is double the standard sickness benefit rate, that is, equal to full wages.</li>\n</ul>\n</li>\n<li data-listid=\"52\" data-aria-posinset=\"9\" data-aria-level=\"1\"><strong>Maternity</strong> Benefit&nbsp;&ndash; benefit is payable at full wages for 26 weeks (6.5 months) for pregnancy, 6 weeks following a miscarriage, and 30 days for sickness arising out of pregnancy. It also covers the premature birth of a child born to an insured woman.</li>\n<li data-listid=\"52\" data-aria-posinset=\"10\" data-aria-level=\"1\"><strong>Dependance</strong> Benefit&ndash; in case of death, as a result of employment injury, the dependents of an insured person are eligible for periodical payments. Pension at the rate of <strong>90%</strong> of the wages is payable, shared by dependants in a fixed ratio, on monthly basis in accordance with the prescribed share. An eligible son or daughter is entitled to the dependant's benefit up to the age of 18; the benefit is withdrawn if the daughter marries earlier.</li>\n<li data-listid=\"52\" data-aria-posinset=\"11\" data-aria-level=\"1\"><strong>Disablement</strong> Benefits&ndash;\n<ul>\n<li data-listid=\"52\" data-aria-posinset=\"11\" data-aria-level=\"1\">Temporary disability- at 90% daily wages as long as the person is disabled.</li>\n<li data-listid=\"52\" data-aria-posinset=\"11\" data-aria-level=\"1\">Permanent disability- lifetime pension. It also covers occupational diseases.</li>\n</ul>\n</li>\n<li data-listid=\"52\" data-aria-posinset=\"11\" data-aria-level=\"1\"><strong>Funeral</strong> Benefit&nbsp;&ndash; a maximum of Rs.15,000/-.</li>\n<li data-listid=\"52\" data-aria-posinset=\"11\" data-aria-level=\"1\"><strong>Rehabilitation</strong> Benefit- on payment of Rs.10, the insured person and his/her family continue to get medical treatment after permanent disablement or retirement.</li>\n</ul>\n<p><strong>To the Employers</strong></p>\n<ul>\n<li data-listid=\"53\" data-aria-posinset=\"4\" data-aria-level=\"1\">Exemption from Workman Compensation Act.</li>\n<li data-listid=\"53\" data-aria-posinset=\"5\" data-aria-level=\"1\">Exemption from Maternity Benefit Act.</li>\n<li data-listid=\"53\" data-aria-posinset=\"6\" data-aria-level=\"1\">Income tax rebate on the amount contributed towards the scheme.</li>\n<li data-listid=\"53\" data-aria-posinset=\"6\" data-aria-level=\"1\">Exemption from payment of medical allowance to employees and their dependants, or arranging for their medical care.</li>\n<li data-listid=\"53\" data-aria-posinset=\"6\" data-aria-level=\"1\">Healthy-work force.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8495",
      "difficulty": "easy"
    },
    {
      "text": "An 18-month-old baby was brought with complaints of fever and fast breathing. According to IMNCI, what should be the respiratory rate to diagnose this baby with pneumonia?<div class='question-desc-html'><p>IMNCI: Integrated management of neonatal and childhood illness&nbsp;</p></div>",
      "choices": [
        {
          "id": 1,
          "text": ">/=40"
        },
        {
          "id": 2,
          "text": ">/=60"
        },
        {
          "id": 3,
          "text": ">/=30"
        },
        {
          "id": 4,
          "text": ">/=50"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>An<strong> 18-month-old</strong>&nbsp;baby presenting with fever and <strong>fast breathing</strong> should have a <strong>respiratory rate</strong> of<strong>&nbsp;<span>&gt;</span>40 </strong>to be diagnosed with <strong>pneumonia</strong>&nbsp;according to <strong>IMNCI</strong>.</p>\n<p>According to the<strong>&nbsp;</strong>IMNCI, three<strong>&nbsp;</strong>key clinical&nbsp;<strong>signs</strong>&nbsp;are used to assess a sick child with suspected pneumonia:</p>\n<ul>\n<li><strong>Respiratory rate</strong>&nbsp;(RR):<strong>&nbsp;d</strong><strong>istinguishes</strong>&nbsp;children who have&nbsp;<strong>pneumonia</strong>&nbsp;from those who do not. Children are classified under pneumonia if:\n<ul>\n<li><strong><span>&gt;</span>&nbsp;60 breaths</strong> per minute if age &nbsp;is <strong>&lt; 2 months&nbsp;</strong></li>\n<li><strong><span>&gt;</span> 50/min</strong>&nbsp;RR for infants <strong>2 months </strong>to<strong> 12 months</strong></li>\n<li><strong><span>&gt;</span> 40/min</strong>&nbsp;RR for children <strong>12 months</strong> to <strong>5 years</strong> of age</li>\n</ul>\n</li>\n<li><strong>Lower chest wall indrawing</strong>&nbsp;refers to the indrawing of the lower chest wall with respect to the child's breathing and indicates&nbsp;<strong>pneumonia</strong></li>\n<li><strong>Stridor&nbsp;</strong>indicates those with&nbsp;<strong>severe pneumonia</strong>&nbsp;requiring hospital<strong>&nbsp;admission.</strong></li>\n</ul>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p>The revised classification of acute respiratory&nbsp;infections is simplified to include only two categories of pneumonia:</p>\n<ul>\n<li>Cough and cold, no pneumonia - requires home remedy</li>\n<li>Pneumonia - with <strong>fast breathing </strong>and/or <strong>chest indrawing</strong>, which requires <strong>home therapy</strong> with <strong>oral amoxicillin</strong>.</li>\n<li>Severe pneumonia - pneumonia with <strong>any general danger sign</strong>, which <strong>requires</strong> a <strong>referral</strong> and <strong>injectable therapy</strong>.&nbsp;</li>\n</ul>\n</div>\n</div>\n<div class=\"ng-scope\"><strong>Danger signs </strong>of severe pneumonia are:&nbsp;</div>\n<ul>\n<li>Not able to drink</li>\n<li>Persistent vomiting</li>\n<li>Convulsions</li>\n<li>Lethargic or unconscious</li>\n<li>Stridor in a calm child</li>\n<li>Severe malnutrition</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/402ec23059f642f1840119590a5d55fdx1280x711.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC8898",
      "difficulty": "medium"
    },
    {
      "text": "A patient with lymphatic filarisis is being managed as shown in the image below. What is the level of prevention done here?",
      "choices": [
        {
          "id": 1,
          "text": "Specific protection"
        },
        {
          "id": 2,
          "text": "Disability limitation"
        },
        {
          "id": 3,
          "text": "Primary prevention"
        },
        {
          "id": 4,
          "text": "Health promotion"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The image shows an established case of <strong>chronic lymphatic filariasis</strong>, where hygiene is being maintained to <strong>prevent further disability</strong> by secondary bacterial infection. Disability limitation is a <strong>mode of intervention</strong> in <strong>tertiary prevention</strong>.</p>\n<p>Other options:</p>\n<p>Option A: <strong>Specific protection</strong> is a <strong>mode of intervention</strong> in primary prevention which aims at <strong>limiting the number of cases of a particular disease</strong>. This includes immunization, use of specific nutrients, chemoprophylaxis, accident protection, and avoidance of allergens.</p>\n<p>Option C:<strong> Primary prevention</strong> is a <strong>level of prevention</strong> which is defined as <strong>action taken prior to the onset of a disease</strong>, which <strong>removes the possibility that a disease will ever occur</strong>. It is accomplished by measures designed to promote general <strong>health</strong> and <strong>well-being.</strong></p>\n<p>Option D: <strong>Health promotion</strong> is a <strong>mode of intervention</strong> in primary prevention, and is the process of enabling people to increase control over, and improve health. Health promotion may be achieved through health education, environmental modification, nutritional interventions or lifestyle changes.</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Levels of Prevention</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Level</strong></p>\n</td>\n<td>\n<p><strong>Primordial</strong></p>\n</td>\n<td>\n<p><strong>Primary</strong></p>\n</td>\n<td>\n<p><strong>Secondary</strong></p>\n</td>\n<td>\n<p><strong>Tertiary</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Phase of disease</strong></p>\n</td>\n<td>\n<p>Underlying socio-economic &amp; environmental conditions leading to causation</p>\n</td>\n<td>\n<p>Specific causal or risk factors</p>\n</td>\n<td>\n<p>Early stage of disease</p>\n</td>\n<td>\n<p>Late stage of disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Aim</strong></p>\n</td>\n<td>\n<p>Establish and maintain conditions that minimize hazards to health</p>\n</td>\n<td>\n<p>Reduce the incidence of disease</p>\n</td>\n<td>\n<p>Reduce prevalence by shortening duration</p>\n</td>\n<td>\n<p>Reduce number and impact of complications</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Actions</strong></p>\n</td>\n<td>\n<p>Inhibition of emergence of socio-economic, environmental and behavioural conditions</p>\n</td>\n<td>\n<p>Protection of personal and community health by eliminating risks</p>\n</td>\n<td>\n<p>Early detection and intervention to minimize disability</p>\n</td>\n<td>\n<p>Soften the impact of long-term disease and disability, minimize suffering</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Modes of Intervention</strong></p>\n</td>\n<td>\n<p>Health education</p>\n</td>\n<td>\n<p>Health promotion and specific protection</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Diagnosis and treatment</p>\n</td>\n<td>\n<p>Disability limitation and rehabilitation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Targets</strong></p>\n</td>\n<td>\n<p>Total population or select groups</p>\n</td>\n<td>\n<p>Total population or high risk individuals/groups</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Individuals/ Patients</p>\n</td>\n<td>\n<p>Patients</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/3c500cb8a7a44c50b725fbc5c432b1b6.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7352",
      "difficulty": "easy"
    },
    {
      "text": "A newborn is found to have hearing loss and bilateral congenital cataracts. The echocardiography reveals a ventricular septal defect. What is false regarding the suspected diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Most commonly associated cardiac defect is patent ductus arteriosus"
        },
        {
          "id": 2,
          "text": "Vertical transmission"
        },
        {
          "id": 3,
          "text": "Infection in early pregnancy causes milder disease"
        },
        {
          "id": 4,
          "text": "Foetus affected in late pregnancy may have only deafness"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The child presents with the classical triad of Congenital<strong>&nbsp;Rubella</strong>&nbsp;Syndrome.</p>\n<p>The <strong>earlier the infection</strong> occurs in pregnancy <strong>the greater the damage</strong> is to the fetus.</p>\n<p>The major determinant of the extent of fetal infection in <strong>Congenital Rubella Syndrome</strong> is the&nbsp;<strong>gestational age</strong> at which fetal transmission occurs.</p>\n<p>Infection in 1<sup>st</sup> trimester:</p>\n<ul>\n<li>Abortions</li>\n<li>Stillbirth</li>\n<li>Skin lesions: <strong>Blueberry muffin</strong> lesions</li>\n<li><strong>Triad</strong> of congenital rubella syndrome\n<ul>\n<li>Sensorineural deafness</li>\n<li>Congenital heart defects &ndash; MC is <strong>PDA</strong></li>\n<li>Cataracts</li>\n</ul>\n</li>\n</ul><hr><h3>Related Pearl: Rubella and congenital rubella syndrome</h3><p><strong>Congenital rubella syndrome</strong>:</p>\n<ul>\n<li>The triad of Gregg in congenital rubella syndrome&nbsp;includes:\n<ul>\n<li><strong>Sensorineural hearing loss -&nbsp;</strong>Nerve deafness is the <strong>single most common</strong> finding among infants with congenital rubella syndrome</li>\n<li>Congenital <strong>cataract</strong></li>\n<li><strong>Congenital heart disease</strong>&nbsp;-<strong>&nbsp;</strong>The most common cardiac defect is&nbsp;<strong>patent ductus arteriosus</strong></li>\n</ul>\n</li>\n<li><strong>Maximum damage</strong> to the fetus occurs in the <strong>first trimester</strong></li>\n<li>Infection in the <strong>second&nbsp;trimester</strong> causes <strong>only</strong> <strong>deafness</strong></li>\n<li>If infection occurs&nbsp;<strong>after 16 weeks</strong> there are <strong>no major abnormalities</strong></li>\n<li>Diagnosis - Presence of IgM rubella antibodies in the infant shortly after birth or persistence of IgG antibodies for &gt;6 months.</li>\n</ul>\n<p>The given image shows <strong>bilateral cataract</strong> in an&nbsp;infant with congenital rubella syndrome</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f6ed3c62561f49ba90d0fb8f2eaa34a9x700x478.JPEG\" alt=\"Pearl Image\"><p>The given image shows <strong>blueberry muffin rash</strong> in an&nbsp;infant with congenital rubella syndrome</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c5ddb3e330a841c3b9ba2c7cd124b750x720x508.PNG\" alt=\"Pearl Image\"><p>The image given below shows the&nbsp;<strong>salt and pepper fundus.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c98db18501ac4a4c8f755bcef23f5267x512x341.PNG\" alt=\"Pearl Image\"><p>&nbsp;<strong>Rubella</strong>:</p>\n<ul>\n<li>Also called the <strong>German measles</strong></li>\n<li>Causative organism belongs to the family <strong>Matonaviridae</strong></li>\n<li>Period of infectivity is -5 to +6 days after the onset of the rash</li>\n<li>Droplet trasmission</li>\n<li>The incubation period is 2-3 weeks</li>\n<li>The rash appears on day 1</li>\n<li><strong>Forchheimer spots are</strong> seen, which are tiny, rose-colored lesions in the oropharynx</li>\n<li>Associated with post-infectious thrombocytopenia</li>\n<li>The most serious complication is&nbsp;<strong>encephalitis</strong></li>\n<li><strong>Vaccination</strong>&nbsp;is done with&nbsp;the <strong>live attenuated RA 27/3 strain</strong> of the rubella</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3605",
      "difficulty": "easy"
    },
    {
      "text": "The critical path in the flow chart given below includes how many days?",
      "choices": [
        {
          "id": 1,
          "text": "3 days"
        },
        {
          "id": 2,
          "text": "12 days"
        },
        {
          "id": 3,
          "text": "9 days"
        },
        {
          "id": 4,
          "text": "15 days"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Critical path is the<strong> longest path</strong> in the network analysis. Here the <strong>red line</strong> signifies the critical path and it includes 9 days.<br /> <br />Any delay in the critical path will delay the entire project.</p><hr><h3>Related Pearl: Network Analysis in Health Management</h3><p>A network is a <strong>graphic plan</strong> of all events and activities to be completed in order to reach an end objective.<br /> <br /> Two types of network analysis: <strong>PERT </strong>and <strong>CPM</strong></p>\n<p>1. Programme Evaluation and Review Technique (PERT)</p>\n<ul>\n<li>An arrow diagram of all events in logical sequence is drawn.</li>\n<li>Time to finish each activity can be calculated and critical activities can be identified.</li>\n<li>It aids in planning, scheduling and monitoring of the project.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/173aa5799bb5492e8a01d82bdda0f6d2x1280x1447.JPEG\" alt=\"Pearl Image\"><p>2. Critical Path Method (CPM)</p>\n<ul>\n<li>The longest path of the network is called the critical path.</li>\n<li>A delay in the critical path will cause a delay in the entire project.</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/d0cfbf9574fd437780d615426200e868.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6159",
      "difficulty": "medium"
    },
    {
      "text": "A nuclear disaster occurs in your state. Which of the following drugs is given prophylactically?",
      "choices": [
        {
          "id": 1,
          "text": "Vitamins E and C"
        },
        {
          "id": 2,
          "text": "Sodium Iodide"
        },
        {
          "id": 3,
          "text": "Potassium Iodide"
        },
        {
          "id": 4,
          "text": "Selenium and Iodized Table Salt"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>After a nuclear disaster, <strong>Potassium Iodide (KI) is given prophylactically</strong> to all people exposed/at risk of exposure to radiation. If taken in time and at the appropriate dosage, KI blocks the thyroid gland uptake of radioactive iodine and thus, <strong>reduces the risk of thyroid cancers.</strong></p>\n<p>Table salt (while it contains KI), does not contain enough iodine to block uptake of radioactive iodine by the thyroid gland.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC8605",
      "difficulty": "hard"
    },
    {
      "text": "Discrete probability distribution that expresses probability of a given number of events in a particular time frame is known as:",
      "choices": [
        {
          "id": 1,
          "text": "Binomial distribution"
        },
        {
          "id": 2,
          "text": "Gaussian distribution"
        },
        {
          "id": 3,
          "text": "Poissons distribution"
        },
        {
          "id": 4,
          "text": "Normal distribution"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>&nbsp;</p>\n<p>Poissons distribution is the probability distribution that describes the chances of an event in a particular time frame.</p>\n<p>For example, if you plot the number of patients visiting the OPD of your hospital for a week on a chart, you can conclude that on a particular day(say Monday) there are more number of patients. And if the pattern of patients is similar you can estimate the number of patients in OPD next week or so.</p>\n<p>It is usually done for rare events and is depends on&nbsp;&mu; =&nbsp;&lambda;t (where&nbsp;&mu; defines the number of events in happening in time t)</p>\n<p>Other options&nbsp;<br />Gaussian distribution is another name for Normal distribution&nbsp;</p>\n<p>Binomial distribution examples consist of those events which can only have two possible results given as yes or no / success or failure. It is usually done for finite number of events unlike Poissons distribution.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6672",
      "difficulty": "medium"
    },
    {
      "text": "Given below is an instrument which is used to measure air humidity. Identify the instrument.",
      "choices": [
        {
          "id": 1,
          "text": "Hygrometer"
        },
        {
          "id": 2,
          "text": "Hydro thermometer"
        },
        {
          "id": 3,
          "text": "Assman Psychrometer"
        },
        {
          "id": 4,
          "text": "Sling Psychrometer"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The instrument seen in the image is a <strong>Sling Psychrometer</strong>, It is used to measure the <strong>humidity/ moisture</strong> content in the air.</p>\n<p>Sling Psychrometer has a 2 mercury thermometers (wet and dry) in it. The wet bulb is moistened first with distilled water and the instrument is whirled / rotated standing with the back to the sun. The reading is noted twice.</p>\n<p>Later the dry bulb is taken up for the reading and the relative air humidity is obtained by use of suitable tables and charts.</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Humidity</h3><p><strong>Absolute humidity </strong>is the <strong>weight of water vapor </strong>in a <strong>unit volume of air</strong> and it is expressed as g/kg of air or g/m<sup>3</sup> of air.</p>\n<p><strong>Relative humidity (RH)</strong>:</p>\n<ul>\n<li>It is the <strong>ratio</strong> of the<strong>&nbsp;</strong>actual water vapor content to the maximum water vapor content&nbsp;in the air required for saturation of air at a given temperature and pressure. It is expressed as a percentage.</li>\n<li><strong>RH = Actual water vapor content x 100/ Total water vapor content</strong></li>\n<li>Very low RH can cause skin problems, irritation of the mucous membranes of the nose and throat, and precipitation of infections.&nbsp;</li>\n</ul>\n<p><strong>Dew point</strong> is the temperature to which air has to be cooled to achieve saturation given the pressure and constant moisture content</p>\n<p><strong>Measurement of humidity:</strong></p>\n<ul>\n<li>Dry and wet hygrometers -&nbsp;most widely used instrument</li>\n<li>Sling or whirling psychrometers</li>\n</ul>\n<p>The following image depicts a whirling psychrometer:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/29634098e945435586ab66cf88c8bd6bx1280x966.JPEG\" alt=\"Pearl Image\"><p>The following image depicts an Assmann psychrometer:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/798c7dccb97244f49f38ac585717ebf4x442x1049.JPEG\" alt=\"Pearl Image\"><p>The following image depicts a dry and wet hygrometer:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/037e621b5ecf4599927a14c00559f352x160x538.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/97c0081a9b424b4da5325a5d8aa90cab.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6164",
      "difficulty": "medium"
    },
    {
      "text": "Vertical transmission of an infectious agent from parent to progeny in vectors is seen in _______",
      "choices": [
        {
          "id": 1,
          "text": "Plague bacilli in rat fleas"
        },
        {
          "id": 2,
          "text": "Borrelia burgdoferi in ticks"
        },
        {
          "id": 3,
          "text": "Rickettsia rickettsii in ticks"
        },
        {
          "id": 4,
          "text": "Malarial parasites in mosquitoes"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Vertical transmission of an infectious agent</strong> from parent to progeny in vectors is called<strong> transovarial transmission. </strong>It&nbsp;is seen in<strong> Rickettsia rickettsii</strong>&nbsp;(in ticks).</p><hr><h3>Related Pearl: Biological Transmission in Vector-Borne Diseases</h3><p><strong>1. Propagative</strong></p>\n<ul>\n<li>The disease agent only multiplies in the vector and there is no change in form.</li>\n<li>E.g., Plague bacilli in rat fleas.</li>\n</ul>\n<p><strong>2. Cyclo-propagative</strong></p>\n<ul>\n<li>The agent changes in form and in number.</li>\n<li>E.g., Malarial parasites in mosquitoes.</li>\n</ul>\n<p><strong>3. Cyclo-developmental</strong></p>\n<ul>\n<li>The agent undergoes only developmental changes and not multiplication.</li>\n<li>E.g., Microfilaria in mosquitoes.</li>\n</ul>\n<p><strong>4. Transovarial</strong></p>\n<ul>\n<li>Infectious agent is transmitted vertically in the vector, from parent to progeny.</li>\n<li>E.g., Rickettsia rickettsii in ticks.</li>\n</ul>\n<p><strong>5. Transstadial</strong></p>\n<ul>\n<li>The infectious agent stays with the vector from one stage of its life cycle to the next.</li>\n<li>E.g., Borrelia burgdorferi in ticks.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4341",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following statements is false about the p-value?",
      "choices": [
        {
          "id": 1,
          "text": "It is equal to the probability of committing a type I error"
        },
        {
          "id": 2,
          "text": "It is equal to 1–beta"
        },
        {
          "id": 3,
          "text": "It is the chance that the presence of difference is concluded when actually there may be none"
        },
        {
          "id": 4,
          "text": "When the p value is less than α, the result is statistically significant"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>power</strong> of a test is&nbsp;<strong>1 &ndash; beta</strong>.</p>\n<p>The <em>p</em> value is the probability that a type I error is being made. It is the chance that the presence of difference is concluded when actually there may be none. When the <strong><em>p</em></strong> value is <strong>less than &alpha;</strong>, the result is statistically <strong>significant</strong>.</p><hr><h3>Related Pearl: Concepts in Hypothesis Testing</h3><p><strong>Probability value (</strong><em>p</em><strong> value)</strong></p>\n<ul>\n<li>A&nbsp;<strong>probability value</strong>&nbsp;is the&nbsp;<strong>probability of an outcome given the hypothesis</strong>.</li>\n<li>It is not the probability of the hypothesis given the outcome, although the probability of the given hypothesis is not ignored.</li>\n<li>If the&nbsp;<strong>probability of an outcome is sufficiently low</strong>, we have&nbsp;<strong>evidence that the hypothesis is false</strong>.</li>\n<li>It is also called the&nbsp;<em>p</em><strong> value</strong>.</li>\n</ul>\n<p><strong>The Null Hypothesis and Alternative Hypothesis</strong></p>\n<ul>\n<li>The <strong>hypothesis that an apparent effect or outcome is only due to chance is a null hypothesis</strong>.</li>\n<li>In other words, a null hypothesis is one where there is <strong>no difference between the specified sample and population</strong> and any observed difference is due to chance or some other error.</li>\n<li>A null hypothesis is represented by <strong>H<sub>0</sub></strong>.</li>\n<li>If the <strong>null hypothesis</strong> is <strong>rejected</strong> as false, then there is an <strong>alternative</strong> or <strong>experimental hypothesis (H<sub>A</sub>)</strong>, which is logically accepted.</li>\n</ul>\n<p><strong>Criterion or Significance Level</strong> <strong>(&alpha;) </strong></p>\n<ul>\n<li>If the probability value of an outcome is sufficiently low, then the null hypothesis is rejected.</li>\n<li>This <strong>point below which we would define the probability value as being low enough</strong> to reject the null hypothesis is called the <strong>criterion</strong> or <strong>significance level </strong>or<strong> &alpha; (alpha) level</strong>.</li>\n<li>When the null hypothesis is rejected, the effect or outcome is said to be <strong>statistically significant</strong>.</li>\n<li>By <strong>convention</strong> (but not always), the <strong>level of &alpha; is 0.05</strong>, i.e., if the probability value of an outcome is <strong>less than or equal to 0.05 (</strong><em>p</em><strong> value &le; 0.05)</strong>, then the null hypothesis is <strong>rejected</strong>.</li>\n<li>If it is <strong>greater than 0.05</strong>, then the null hypothesis is <strong>accepted</strong>.</li>\n<li>Although by convention the level of <strong>&alpha; is 0.05</strong>, it can be lower but cannot be any higher.</li>\n</ul>\n<p><strong>Type I Error</strong></p>\n<ul>\n<li>The interpretation of <strong><em>p</em> value &le; 0.05 </strong>is that an investigator can be 95% sure that the result was not obtained by chance.</li>\n<li>It also means that there is a 5% probability that the result was obtained by chance.</li>\n<li>From this, we can deduce that the <strong>null hypothesis might indeed be true even though we rejected it</strong>.</li>\n<li>This is <strong>a type I error</strong>. In other words, <strong>when an alternative hypothesis is accepted even when it is false and the null hypothesis is true</strong>, it is a <strong>type I error</strong> or <strong>false positive error</strong>.</li>\n<li>It is also called an <strong>alpha (&alpha;) error</strong> as it is <strong>related to the criterion &alpha;</strong>.</li>\n<li>The <strong>lower the &alpha; level</strong>, the <strong>lower the rate of a type I error</strong> being made.</li>\n<li>Thus, it can be said that <strong>&alpha; is the maximum tolerable probability that a type I error is being made</strong> and that the <strong>p value is the probability that a significant difference is declared when there is none</strong>.</li>\n</ul>\n<p><strong>Type II Error</strong></p>\n<ul>\n<li>The error that is made by <strong>rejecting an alternative hypothesis when it is true</strong> or <strong>failing to reject a null hypothesis when it is false</strong> is called a <strong>type II error</strong>.</li>\n<li>It is also called a <strong>false negative error </strong>and more commonly, as a <strong>beta (&beta;) error</strong>.</li>\n<li>If the null hypothesis is false, then the <strong>probability of a type II error</strong> is <strong>&beta;</strong>.</li>\n<li>The <strong>power of a statistical test</strong> is indicated by <strong>1&ndash;&beta;.</strong></li>\n</ul>\n<p><strong>Power of a Test</strong></p>\n<ul>\n<li>The <strong>power of a test</strong> is the <strong>ability</strong> of a statistical test to <strong>avoid a type II error</strong>, which depends on its <strong>ability to detect a false null hypothesis</strong>.</li>\n<li>It is <strong>equal to 1&ndash;&beta;</strong>, which is the <strong>probability that a false null hypothesis will be rejected</strong>.</li>\n<li>By <strong>convention</strong>, a test is required to have a <strong>power of 0.8</strong> (or a <strong>&beta; of 0.2</strong>) to be <strong>acceptable</strong>. This is to say that a study that has less than 80% chance of detecting a false null hypothesis is unacceptable.</li>\n<li><strong>Type I errors are easily reduced by reducing the criterion &alpha;</strong>.</li>\n<li>A <strong>test's power will increase</strong> in the following conditions:\n<ul>\n<li>If <strong>&alpha; increases</strong>, but this will increase the chance of a type I error.</li>\n<li>If the <strong>difference between </strong>the <strong>sample mean </strong>and<strong> hypothesized mean increases</strong>. This is also called <strong>effect size</strong>.</li>\n<li>If <strong>sampling error decreases</strong>.</li>\n<li>If the <strong>sample size (n) increases</strong>.</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2648",
      "difficulty": "medium"
    },
    {
      "text": "What is the nature of the data seen in the graphical plot below?",
      "choices": [
        {
          "id": 1,
          "text": "Positively skewed distribution"
        },
        {
          "id": 2,
          "text": "Negatively skewed distribution"
        },
        {
          "id": 3,
          "text": "Normal distribution"
        },
        {
          "id": 4,
          "text": "Left skewed distribution"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In the image, the&nbsp;<strong>tail of the distribution is towards the positive direction</strong>&nbsp;and thus it is&nbsp;<strong>positively skewed or right-skewed distribution.</strong></p>\n<p>To further understand and correlate the data representation with that of a corresponding box and whisker plot, have a look at the following images:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a8627ad901984d5ba73af62c9f117f17x650x1175.PNG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/61641c5825e04bdaab48c22de2284cc8x785x1452.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Mean, Median, Mode in Different Distribution Shapes</h3><ul>\n<li>The relationship between the mean, median and mode depends upon the distribution.</li>\n<li>In a <strong>unimodal symmetrical </strong>distribution like a <strong>normal distribution</strong>, all the <strong>three measures</strong> are approximately the<strong> same</strong>, as shown in Figure (2) in the following image, i.e., <strong>mean = median = mode.</strong></li>\n<li>Figure (3) in the following image shows a <strong>positively skewed</strong> distribution in which the <strong>longer tail </strong>is towards the<strong> positive direction</strong>. In this, the mean will be larger than the median and mode, i.e., <strong>mean &gt; median &gt; mode.</strong></li>\n<li>Figure (1) in the following image shows a <strong>negatively skewed</strong> distribution in which the <strong>longer tail </strong>is towards the<strong> negative direction</strong>. In this, the mean will be smaller than the median, i.e., <strong>mean &lt; median &lt; mode.</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d79321686162499ca8b9174d58e8f7aex1280x2893.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p>Unimodal <strong>symmetrical distribution</strong></p>\n</td>\n<td>\n<p><strong>Mean = Median = Mode</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Positively (right) skewed</strong> distribution</p>\n</td>\n<td>\n<p><strong>Mean &gt; Median &gt; Mode</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Negatively (left) skewed</strong> distribution</p>\n</td>\n<td>\n<p><strong>Mean &lt; Median &lt; Mode</strong></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li>As seen in the figures above, in any distribution curve, the <strong>mode </strong>is generally the<strong> highest point</strong>. The <strong>mean</strong> will be pulled up or down <strong>based </strong>on the<strong> values</strong> in the distribution. The <strong>median </strong>will lie<strong> between</strong> the <strong>mode</strong> and <strong>mean</strong> and <strong>divide</strong> the distribution in two<strong> equal halves</strong> under the curve.</li>\n<li>A <strong>bimodal distribution</strong> will have <strong>two high</strong> points as shown in the image below.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/25c3b8cb808949c2891e9d098cd1ab54x1280x1007.JPEG\" alt=\"Pearl Image\"><ul>\n<li>Mathematically, the relationship between mode, median and mean in <strong>asymmetrical</strong> distributions can be given as:<br /><strong>Mode = 3 median – 2 mean</strong> (or) <strong>Mean = ½ (3 median – mode).</strong></li>\n<li><strong>Outlier </strong>is the statistical term used for an <strong>observation </strong>or value that is<strong> very distant </strong>from<strong> other </strong>observations in the distribution.</li>\n<li>In a distribution with <strong>outliers</strong>, <strong>preferred </strong>measure of central tendency is the <strong>median</strong>.</li>\n<li><strong>Mode </strong>is <strong>least </strong>affected<strong> by outliers</strong> but <strong>mean </strong>is the <strong>most</strong> affected out of all the measures of location.</li>\n</ul><hr><h3>Related Pearl: Box and Whisker Plot</h3><ul>\n<li>A box and whisker plot is used to show <strong>variation in a set of data</strong>.</li>\n<li>They can summarize data from various sources and display it in a single graph.</li>\n<li>A box and whisker plot is usually based on <strong>median, quartiles and percentiles</strong>.</li>\n<li>It is also called a <strong>box plot.</strong></li>\n<li>In the box plot as shown in the image, a simple box is divided into two by the <strong>median value</strong>. Above and below it are the <strong>whiskers</strong>. The top and bottom ends of the whiskers are the <strong>highest and lowest value of that group</strong>.&nbsp;</li>\n</ul><ul>\n<li>A box plot can help in identifying <strong>outliers</strong> and the <strong>interquartile range (IQR), </strong>as shown in the image below.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/557efa950e5f407ca148010054728d60x314x146.PNG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/c0de164b968848e7b0819bba71b6e18b.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5846",
      "difficulty": "easy"
    },
    {
      "text": "Match the following phases of the demographic cycle with their correct description.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td>1. High stationary</td>\n<td>a. Birth rate is less than death rate</td>\n</tr>\n<tr>\n<td>2. Early expanding</td>\n<td>b. Both birth rate and death rate are at a low level</td>\n</tr>\n<tr>\n<td>3. Low stationary</td>\n<td>c.&nbsp;High birth rate and high death rate</td>\n</tr>\n<tr>\n<td>4. Declining stage</td>\n<td>d.&nbsp;Death rate starts falling but birth rate remains high</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>e. Further fall in the death rate, with the birth rate beginning to fall</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-c, 2-a, 3-b, 4-e"
        },
        {
          "id": 2,
          "text": "1-c, 2-d, 3-b, 4-a"
        },
        {
          "id": 3,
          "text": "1-b, 2-e, 3-b, 4-a"
        },
        {
          "id": 4,
          "text": "1-c, 2-b, 3-a, 4-d"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The correct match is:</p>\n<table>\n<tbody>\n<tr>\n<td>1. High stationary</td>\n<td>c. High birth rate and high death rate</td>\n</tr>\n<tr>\n<td>2. Early expanding</td>\n<td>d. Death rate starts falling but birth rate remains high</td>\n</tr>\n<tr>\n<td>3. Low stationary</td>\n<td>b. Both birth rate and death rate are at a low level</td>\n</tr>\n<tr>\n<td>4. Declining stage</td>\n<td>a. Birth rate is less than death rate</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<div class=\"ng-scope\">&nbsp;</div><hr><h3>Related Pearl: Demographic Process and Cycle</h3><p><strong>Stages </strong>of the<strong> demographic cycle</strong> include:</p>\n<ul>\n<li><strong>Stage 1 - High stationary</strong>&nbsp;\n<ul>\n<li><strong>High birth rates </strong>and <strong>high death rates</strong> render the population <strong>stationary</strong></li>\n<li>Narrow demographic gap</li>\n</ul>\n</li>\n<li><strong>Stage 2 - Early expanding&nbsp;</strong>\n<ul>\n<li>The <strong>death rate declines</strong> and the&nbsp;<strong>birth rate</strong> remains<strong> unchanged</strong></li>\n<li>The <strong>demographic gap</strong> starts <strong>increasing </strong>and becomes<strong> maximum</strong></li>\n</ul>\n</li>\n<li><strong>Stage 3 - Late expanding</strong>\n<ul>\n<li><strong>Death rate</strong> <strong>declines </strong>further and <strong>birth rate falls</strong></li>\n<li><strong>India</strong> is in this stage, currently</li>\n<li>The <strong>demographic gap</strong> starts <strong>declining</strong></li>\n</ul>\n</li>\n<li><strong>Stage 4 - Low stationary</strong>&nbsp;\n<ul>\n<li><strong>Low birth rate</strong> and <strong>low death rate </strong>renders the population <strong>stationary</strong></li>\n<li>Narrow demographic gap</li>\n</ul>\n</li>\n<li><strong>Stage 5 - Declining&nbsp;</strong>\n<ul>\n<li>The <strong>population </strong>begins to<strong> decline</strong> as the birth rate is lower than the death rate</li>\n<li>The<strong> demographic gap</strong> is <strong>negative</strong></li>\n</ul>\n</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/195bd20c6832444caf57ca79ed76b70dx1280x1145.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Demographic Aspects of India</h3><p><strong>UN Data (2021) </strong></p>\n<ul>\n<li>India&rsquo;s <strong>population</strong>&nbsp;was <strong>1,393,409,000&nbsp;</strong>(1.39 Billion)&nbsp;</li>\n<li>In 2021, India ranked&nbsp;<strong>2<sup>nd</sup> </strong>in the list of countries with the highest population</li>\n<li>Almost <strong>34.5%</strong> of India&rsquo;s population is <strong>urban</strong></li>\n<li>The population <strong>growth rate</strong> was&nbsp;<strong>1%</strong></li>\n</ul>\n<p><strong>SRS Statistical Report (2020)<br /></strong></p>\n<p>Vital statistics according to&nbsp;the Sample Registration System data released by the Registrar General of India:</p>\n<ul>\n<li>Infant mortality rate (<strong>IMR</strong>) in India -<strong> 28 per 1000 live births</strong></li>\n<li>The crude birth rate (<strong>CBR</strong>) - <strong>19.5</strong></li>\n<li>The crude death rate (<strong>CDR</strong>) was<strong> 6.0</strong></li>\n</ul><hr><h3>Related Pearl: Population Pyramid</h3><ul>\n<li>The <strong>age or population pyramid</strong> is used to represent the age/sex structure of a population.</li>\n<li>Below is the <strong>age pyramid of India</strong> (2017).</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fe5271a4a221480f809114549d9e0b7dx800x600.PNG\" alt=\"Pearl Image\"><ul>\n<li>The age pyramid of India has a <strong>broad base</strong> and a <strong>tapering top</strong>, as it is with <strong>most developing countries</strong>.</li>\n<li>As a nation develops the lower portion of the pyramid will start constricting and the upper portion will start increasing.&nbsp;</li>\n<li><strong>Developed countries</strong> usually will have a <strong>bulge in the middle with a narrow base</strong>, as shown below in the age pyramid of <strong>Switzerland.</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9f72b363d41241e49d64b0341554818fx610x425.PNG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8475",
      "difficulty": "easy"
    },
    {
      "text": "Anti-larval measures are being taken to control the mosquitoes, which were breeding in a pond. All of the following are fishes, which may be used in biological control, except:",
      "choices": [
        {
          "id": 1,
          "text": "Cyclops"
        },
        {
          "id": 2,
          "text": "Gambusia"
        },
        {
          "id": 3,
          "text": "Barbados millions"
        },
        {
          "id": 4,
          "text": "Poecilia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Cyclops</strong> is a<strong> crustacean </strong>(omnivorous copepod), which belongs to the phylum <strong>Arthropoda.</strong> It is <strong>not a fish. </strong>However, the <strong>cyclops can also feed on larval stages</strong> of some mosquito species, and <strong>can be used in biological control.</strong></p>\n<p>The <strong>larvivorous fishes</strong> that can be used for<strong> biological control</strong> include:</p>\n<ul>\n<li><strong>Gambusia</strong> affinis</li>\n<li>Lebister reticulatus (<strong>Barbados</strong> Millions)</li>\n<li><strong>Poecilia</strong></li>\n</ul><hr><h3>Related Pearl: Mosquito Control Measures</h3><ul>\n<li><strong>Anti-larval measures</strong>\n<ul>\n<li><strong>Environmental control</strong>\n<ul>\n<li>This is done by <strong>source reduction</strong> by <strong>eliminating breeding places</strong> through appropriate methods for the different species.</li>\n<li><strong>Intermittent irrigation</strong> is also a method of environmental control</li>\n</ul>\n</li>\n<li><strong>Chemical control</strong>\n<ul>\n<li><strong>Mineral oils</strong>: Oldest known larvicidal method. Oils that are used are diesel oil, kerosene, crude oil fractions. Disadvantage is that it kills fish.</li>\n<li><strong>Paris green</strong>: Copper acetoarsenite is an emerald green, micro-crystalline powder and is insoluble in water. It is a <strong>stomach poison</strong> to larvae. It is not harmful to man or animals. Very effective against Anopheles as they are surface feeders.</li>\n<li><strong>Synthetic insecticides</strong>: Organo-phosphorous compounds like fenthion, chlorpyrifos and abate are larvicidal. Abate is least toxic.</li>\n</ul>\n</li>\n<li><strong>Biological control</strong>\n<ul>\n<li>The fish species <strong>Gambusia affinis</strong> and <strong>Lebister reticulatus</strong> (Barbados millions) feed on mosquito larvae.</li>\n<li>These are used in conjunction with other methods.</li>\n</ul>\n</li>\n</ul>\n</li>\n<li><strong>Anti-adult measures</strong>\n<ul>\n<li><strong>Residual sprays</strong>\n<ul>\n<li>Adult mosquitoes can be controlled by spraying with residual insecticides like <strong>DDT, Malathion, propoxur</strong> and<strong> gamma-HCH (lindane)</strong></li>\n<li><strong>Resistance</strong> to <strong>DDT</strong> has been shown by mosquitoes</li>\n</ul>\n</li>\n<li><strong>Space sprays</strong>\n<ul>\n<li>Space sprays are those in which <strong>insecticides</strong> are <strong>sprayed</strong> into the atmosphere in the form of a <strong>mist or fog</strong>.</li>\n<li><strong>Pyrethrum</strong> is a <strong>contact</strong>, <strong>nerve poison</strong> and is the most common insecticide used as a space spray. Its active principle is pyrethrin.</li>\n<li><strong>Ultra-low volume</strong> space spraying (ULV) is done with <strong>Malathion and fenitrothion.</strong></li>\n</ul>\n</li>\n<li><strong>Genetic control</strong> by sterile male technique, cytoplasmic incompatibility, sex distortion, etc.</li>\n</ul>\n</li>\n<li><strong>Protection against bites</strong>\n<ul>\n<li>Usage of <strong>mosquito nets</strong>, building screens and <strong>repellants </strong>like diethyltoluamide (deet), indalone, dimethylphthalate, dimethyl carbate, etc.</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4269",
      "difficulty": "easy"
    },
    {
      "text": "Choose the most appropriate option regarding 'Reference Indian adult man'.<div class='question-desc-html'><ol>\n<li>He is aged between 19-39 years</li>\n<li>He weighs 75 kg</li>\n<li>His BMI is 20.75</li>\n<li>His height is 1.77m</li>\n<li>He is free from disease and physically fit for active work</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1 and 3 are incorrect"
        },
        {
          "id": 2,
          "text": "1 and 2 are incorrect"
        },
        {
          "id": 3,
          "text": "Only 2 is incorrect"
        },
        {
          "id": 4,
          "text": "Only 3 is incorrect"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Only statement 2 is incorrect as a reference Indian adult man weighs <strong>65 kg.</strong></p>\n<p>An adult man is considered a <strong>reference Indian adult man </strong>if :</p>\n<ul>\n<li>he is aged between 19-39 years</li>\n<li>he weighs 65 kg</li>\n<li>his height is 1.77m</li>\n<li>his BMI is 20.75</li>\n<li>he is engaged in 8 hours of occupation and 8 hours of sleep</li>\n<li>he spends 4-6 hours sitting and moving about, 2 hours walking and in active recreation</li>\n<li>he is free from disease and physically fit for active work. </li>\n</ul>\n<p> </p><hr><h3>Related Pearl: Reference Indian Man and  Woman</h3><table>\n<tbody>\n<tr>\n<td><strong>Parameters </strong></td>\n<td><strong>Reference Indian adult man&nbsp;&nbsp;</strong></td>\n<td><strong>Reference Indian adult&nbsp;woman&nbsp; - non pregnant, non lactating</strong></td>\n</tr>\n<tr>\n<td>Age</td>\n<td>19-39 years&nbsp;&nbsp;</td>\n<td>19-39 years&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td>Weight&nbsp;</td>\n<td>65kg&nbsp;</td>\n<td>55 kg&nbsp;</td>\n</tr>\n<tr>\n<td>Height&nbsp;</td>\n<td>1.77m&nbsp;</td>\n<td>1.62m&nbsp;</td>\n</tr>\n<tr>\n<td>BMI&nbsp;</td>\n<td>20.75</td>\n<td>20.95</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8472",
      "difficulty": "medium"
    },
    {
      "text": "Match the following triage tags with the example of the patient given.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td><strong>Triage tag</strong></td>\n<td><strong>Patient</strong></td>\n</tr>\n<tr>\n<td>1. Black</td>\n<td>A. Tension pneumothorax</td>\n</tr>\n<tr>\n<td>2. Red</td>\n<td>B. Degloving injury</td>\n</tr>\n<tr>\n<td>3. Green</td>\n<td>C. Extensive third-degree burns</td>\n</tr>\n<tr>\n<td>4. Yellow</td>\n<td>D. Fracture of the forearm</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-A, 2-D, 3-B, 4-C"
        },
        {
          "id": 2,
          "text": "1-B, 2-C, 3-A, 4-D"
        },
        {
          "id": 3,
          "text": "1-C, 2-A, 3-D, 4-B"
        },
        {
          "id": 4,
          "text": "1-D, 2-B, 3-C, 4-A"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The correct option is&nbsp;<strong>1-C, 2-A, 3-D, 4-B</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Triage tag</strong></td>\n<td><strong>Patient</strong></td>\n</tr>\n<tr>\n<td>1. Black</td>\n<td>C. Extensive third-degree burns</td>\n</tr>\n<tr>\n<td>2. Red</td>\n<td>A. Tension pneumothorax</td>\n</tr>\n<tr>\n<td>3. Green</td>\n<td>D. Fracture of the forearm</td>\n</tr>\n<tr>\n<td>4. Yellow</td>\n<td>B. Degloving injury</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Triage is used to&nbsp;<strong>classify the priority of treatment.</strong></p>\n<p>It is carried out at the site of the disaster to determine the&nbsp;<strong>priority for immediate medical attention</strong>,&nbsp;<strong>transportation, and</strong>&nbsp;<strong>admission</strong>&nbsp;to the hospital.</p>\n<p>Triage includes rapid classification of the injured based on their injuries and the chances of survival with prompt medical intervention. It provides maximum benefit to the greatest number of injured in a disaster situation. Higher priority is given to victims whose prognosis would be good with simple medical care. Lower priority is given to moribund patients who would have questionable benefits even with medical attention.</p>\n<p>The internationally accepted&nbsp;<strong>four-color coded</strong>&nbsp;system is used commonly. It includes:</p>\n<ul>\n<li>Red - High priority attention or transfer;&nbsp;Critical, but likely to survive if treatment is given early</li>\n<li>Yellow - Medium priority;&nbsp;Critical, likely to survive if treatment is given within hours</li>\n<li>Green - Ambulatory patients;&nbsp;Stable, likely to survive even if treatment is delayed for hours to days</li>\n<li>Black - Dead or moribund patients;&nbsp;Not breathing, pulseless, so severely injured that no medical care is likely to help</li>\n</ul><hr><h3>Related Pearl: Triage Colour Coding</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/515d17fd0b684f8b9cd1fd57ef97b7e6x454x304.PNG\" alt=\"Pearl Image\"><p>&nbsp;<strong>Triage system </strong>consists of <strong>four colour codes:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Color code</strong></td>\n<td><strong>Type of patients</strong></td>\n<td><strong>Examples</strong></td>\n</tr>\n<tr>\n<td><span>Red (High priority)<br /></span></td>\n<td>\n<p>Need for<strong> immediate resuscitation or surgery</strong> in the next<strong> 6 hours</strong> or transfer.</p>\n<p>May survive if timely medical intervention can be given</p>\n</td>\n<td>\n<ul>\n<li>Tension pneumothorax</li>\n<li>Airway obstruction</li>\n<li>Hemothorax</li>\n<li>Cardiac tamponade</li>\n<li>Acute circulatory arrest</li>\n<li>Major intra-abdominal bleed etc.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><span>Yellow (Medium priority)<br /></span></td>\n<td>\n<p>Possible <strong>resuscitation or surgery</strong> in the <strong>next 24 hours</strong>.</p>\n<p>Likely to survive if prompt treatment is given.</p>\n</td>\n<td>\n<ul>\n<li>Compound fractures</li>\n<li>Degloving injuries</li>\n<li>Pelvic fracture</li>\n<li>Spinal injuries</li>\n<li>Moderate head injury</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><span>Green (Low priority)<br /></span></td>\n<td>\n<p><strong>Ambulatory patients</strong> or minor illnesses.</p>\n<p>Likely to survive if treatment is slightly delayed.</p>\n</td>\n<td>\n<ul>\n<li>Simple fractures</li>\n<li>Minor lacerations etc.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Black (Least priority)</td>\n<td>\n<p><strong>Dead or moribund</strong> patients.</p>\n</td>\n<td>\n<ul>\n<li>Severe brain injury</li>\n<li>Major damage / disruption to chest wall and abdominal structures</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0960",
      "difficulty": "easy"
    },
    {
      "text": "As per the WHO guidelines, you should advise repeating the previous dose, if there is an interruption of the primary series of vaccination for which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "Yellow fever"
        },
        {
          "id": 2,
          "text": "Injectable Polio Vaccine"
        },
        {
          "id": 3,
          "text": "Ty21a"
        },
        {
          "id": 4,
          "text": "Oral polio vaccine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Among the given options, only Ty21a requires repeating the previous dose if there is an interruption of the primary series.&nbsp;</p>\n<p>Even for Ty21a, if interruption between doses is <strong>&lt;21 days,</strong> <strong>resume without repeating</strong>&nbsp;the previous dose. If <strong>&gt;21 days, restart the primary</strong> series.&nbsp;</p>\n<p>The yellow fever vaccine is just a single dose. OPV &amp; IPV both do not require repetition of doses in case of interrupted primary series. The vaccination can simply be resumed without repeating the previous doses. Other common vaccines which do not require a repetition in the event of interrupted primary series:</p>\n<ul>\n<li>Hep B</li>\n<li>DTP</li>\n<li>Hib</li>\n<li>PCV</li>\n<li>Rotavirus</li>\n<li>Measles</li>\n<li>JE</li>\n<li>Meningococcal vaccine</li>\n<li>Rabies</li>\n<li>Varicella</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5705",
      "difficulty": "hard"
    },
    {
      "text": "In a study that investigates the relationship between steroid contraceptives and breast cancer, there is found to be a strong association between age and breast cancer, resulting in a confounding bias. Which of the following is an approach to eliminate such an association?<div class='question-desc-html'><ol>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Restriction</span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Randomization</span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Blinding</span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Pre-Stratification</span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Deletion </span></li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2, 3"
        },
        {
          "id": 2,
          "text": "1, 2, 4"
        },
        {
          "id": 3,
          "text": "3, 4, 5"
        },
        {
          "id": 4,
          "text": "1, 4, 5"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<div>The correct answer is <strong>1, 2, 4.</strong></div>\n<div> </div>\n<div>In the given study <strong>age</strong> is found to be a <strong>confounding factor</strong>. <strong>Confounding</strong> <strong>bias</strong> in the given study with age as a confounding factor can be eliminated by <strong>restriction, randomization, </strong>and<strong> <span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">pre-</span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">stratification</span></strong>. </div>\n<div> </div>\n<div><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">A<strong> confounding factor </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">is defined as one </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>associated </strong>with<strong> both exposure and disease </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">and is distributed </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>unequally </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">in study and control groups. </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">In the given example, if the study is conducted without eliminating the confounding factor,</span></span> there is an unexpectedly strong association between the confounding factor (e.g.. age) and the disease (e.g., breast cancer)<br /><br /></div>\n<div> <span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Techniques to eliminate confounding factors include:</span></div>\n<ul class=\"listtype-bullet listindent1 list-bullet1\">\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Randomization</span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Matching</span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Stratified randomization</span></li>\n<li><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Restriction</span></li>\n</ul>\n<div><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>Randomization </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">is the random allocation of the participants in </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>experimental </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>studies </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z h-lparen\">(Randomized</span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"> control trials) into the study group and control group.<br /><br /></span></div>\n<div><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>Matching</strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">, which is usually done in </span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>analytical </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>studies </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z h-lparen\">(for example, case-control</span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"> and cohort studies), is the process where the participants in two groups are matched based on factors such as age, gender, race, smoking status, etc. to eliminate the potential confounders.</span></div>\n<div> </div>\n<div><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>Stratified randomization</strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">, which is also known as <strong>pre-</strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>stratification </strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">or blocking, is the process that combines both randomization and matching techniques. In this method, the participants are first grouped into subgroups that internally match with potential confounding factors such as age, race, gender, etc. An equal number of participants from each subgroup are then allocated to the study and control groups.</span></div>\n<div> </div>\n<div><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\"><strong>Restriction</strong></span><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">: This method restricts the study to only those participants with particular characteristics. For example, a study can be restricted to participants of only one gender, race, age group, geographical area, disease severity, etc., thus eliminating the potential confounders.</span></div>\n<div> </div>\n<div><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Other options:</span></div>\n<div> </div>\n<div><span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z\">Blinding and deletion do not eliminate confounding factors. Blinding is done to eliminate other biases <span class=\" author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qoxwyy7z90zx1z73zz86z8z72z3z70zvjbz81zz122znz90zz74z1z78zz67zz66zz122zz83zjz73ziz69z h-lparen\">such as subject </span>bias, observer bias, or investigator bias.</span></div><hr><h3>Related Pearl: Bias in Epidemiological Studies</h3><table>\n<tbody>\n<tr>\n<td><strong>Type of Bias</strong></td>\n<td><strong>Definition</strong></td>\n<td><strong>Methods to reduce it</strong></td>\n</tr>\n<tr>\n<td>Observer bias</td>\n<td>Differential ability to observe. A <strong>subjective</strong> bias.</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Interviewer's bias</td>\n<td>Interviewer asking <strong>leading questions</strong> to the subjects. Or interviewing cases thoroughly than the controls.</td>\n<td>&nbsp;Double blinding</td>\n</tr>\n<tr>\n<td>Memory/ <strong>Recall</strong> bias</td>\n<td>Differential ability of cases and controls <strong>to recall</strong> a certain detail. An <strong>objective</strong> bias.</td>\n<td>Decrease time from exposure to follow-up</td>\n</tr>\n<tr>\n<td>Surveillance bias</td>\n<td>Active surveillance leads to an <strong>increased chance</strong> of <strong>identifying</strong> the event.</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Reporting/ notification bias</td>\n<td>Diseases associated with <strong>stigma</strong> are <strong>reported less.</strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Berkesonian</strong> bias</td>\n<td><strong>Hospital-based case-control studies.</strong> Occurs due to differential hospital admission rates.</td>\n<td>\n<p>Randomization or Matching&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Selection bias</td>\n<td>A <strong>sampling bias.</strong> Non-random allocation of subjects that do not represent the population</td>\n<td>Randomization or Matching</td>\n</tr>\n<tr>\n<td><strong>Hawthorne</strong> bias</td>\n<td><strong>Change</strong> in <strong>attitude/</strong> actions of the subjects under <strong>observation</strong></td>\n<td>Use placebo group</td>\n</tr>\n<tr>\n<td><strong>Confounding</strong> bias</td>\n<td><strong>Factors related</strong> to <strong>both exposure</strong> and <strong>outcome</strong> distort the effect of exposure on outcome</td>\n<td>Matching, cross-over studies, randomization, or stratification</td>\n</tr>\n<tr>\n<td>Attrition bias</td>\n<td>Participants <strong>lost to follow-up</strong> have a different prognosis than those who complete the study.</td>\n<td>Randomization</td>\n</tr>\n<tr>\n<td>Pygmalion bias</td>\n<td><strong>Researcher's</strong> high <strong>expectations</strong> in the efficacy of the treatment <strong>change</strong> the <strong>outcome</strong> of that treatment.</td>\n<td>Blinding</td>\n</tr>\n<tr>\n<td><strong>Neyman's/</strong> Prevalence-Incidence bias&nbsp;</td>\n<td>Occurs due to the <strong>selective survival</strong> in <strong>prevalent cases</strong> usually seen in <strong>fatal diseases.</strong> Very sick patients are automatically excluded because of their early death.</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Neyman&rsquo;s</strong> bias or prevalence-incidence bias example: a case-control study is carried out to study the relationship between tobacco smoking and acute myocardial infarction (AMI). The cases are interviewed one week after the coronary attack. If smoker patients with AMI die more frequently, the living cases will show a lower frequency of smoking, undervaluing the association between smoking and AMI. It has been shown that the bias occurs only if the risk factor influences mortality from the disease being studied.</p>\n<p><strong>Ecological fallacy</strong> results when characteristics of the group are assigned inappropriately to individuals.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8468",
      "difficulty": "medium"
    },
    {
      "text": "All of the following statements are true regarding prevalence, except?",
      "choices": [
        {
          "id": 1,
          "text": "Refers specifically to all current cases(old and new)"
        },
        {
          "id": 2,
          "text": "It is a rate in the true sense"
        },
        {
          "id": 3,
          "text": "Prevalence = Incidence X mean duration"
        },
        {
          "id": 4,
          "text": "Helps to estimate the magnitude of health problems in the community"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Although <strong>prevalence</strong> is referred to as rate, it is <strong>actually a</strong> <strong>proportion</strong>. The term disease prevalence refers specifically to <strong>all current cases</strong> (<strong>old and new</strong>) in a given population.</p>\n<p>It is represented by the formula :</p>\n<p>Prevalence = (Number of existing cases of a specified disease during a given period of time interval / Estimated mid-interval population at-risk) x 100</p>\n<p>Prevalence depends upon 2 factors, the incidence, and duration of illness. Given the assumption that the population is stable, and incidence and duration are unchanging, the relationship between incidence and prevalence can be expressed as :</p>\n<p><strong>P = I x D   </strong>where,</p>\n<ul>\n<li>P is the prevalence</li>\n<li>I is the incidence</li>\n<li>and D is the mean duration of the disease</li>\n</ul>\n<div class=\"page\" title=\"Page 77\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Prevalence is of two types:</p>\n<p>(a) <strong>Point prevalence</strong>: Point prevalence of a disease is defined as the number of all current cases (old and new) of a disease at<strong> one point</strong> of time, in relation to a defined population.</p>\n<div class=\"page\" title=\"Page 77\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>(b) <strong>Period prevalence</strong>: It measures the frequency of all current cases (old and new) existing during a <strong>defined period</strong> of time (e.g., annual prevalence) expressed in relation to a defined population.</p>\n<div class=\"page\" title=\"Page 78\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Prevalence helps to estimate the <strong>magnitude</strong> of <strong>health problems</strong> in the <strong>community</strong> and identify potential high-risk populations. Prevalence rates are useful for administrative and planning purposes.</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Incidence and Prevalence</h3><ul>\n<li><strong>Incidence</strong> <strong>in Epidemiology:</strong></li>\n</ul>\n<p><strong>Incidence</strong> is the number of <strong>new</strong> <strong>cases</strong> occurring in a defined population during a period of time. The incidence rate is expressed in <strong>person-time</strong> units, usually per 1000 per year. It is given by the following formula:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6f6cc8bc207d4585865b98fbe2659e6ax1280x274.JPEG\" alt=\"Pearl Image\"><p>It is generally used for <strong>acute illnesses. </strong>It provides insight into the <strong>effectiveness of health services and programs. </strong>Incidence can be determined from <strong>cohort studies and longitudinal studies.</strong></p>\n<p>The incidence rate of <strong>spells of sickness</strong> =  (Number of spells of sickness starting in the specified period/Mean number of people exposed to that risk in the specified time) x <strong>1000.</strong></p>\n<p>Special types of incidence rates:</p>\n<p>1.<strong> Attack rate: </strong>It is used when there is a risk for a limited period of time.</p>\n<p>2.<strong> Secondary attack rate: </strong>It is the number of exposed persons developing the disease within the range of incubation period following exposure to a primary case.</p>\n<ul>\n<li><strong>Prevalence in Epidemiology:</strong></li>\n</ul>\n<p>Prevalence is the proportion of all cases, <strong>old and new</strong>, of a particular disease at a given point in time or over a period of time in a given population. It is a <strong>proportion,</strong> not a rate or ratio. Prevalence is always expressed in <strong>percentage.</strong></p>\n<p>It is given by the formula:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e91eaa37efa84edd8f721ab2d87a9a13x1280x274.JPEG\" alt=\"Pearl Image\"><p>It is useful to determine the <strong>magnitude </strong>of health problems. It can be determined from <strong>cross-sectional studies.</strong></p>\n<p>Types:</p>\n<p>1. <strong>Point </strong>prevalence is the prevalence at a point in time. Usually, prevalence is point prevalence unless <strong>otherwise specified</strong>.</p>\n<p>2. <strong>Period</strong> prevalence is the prevalence over a period of time.</p>\n<p><strong>Relationship</strong> between<strong> Incidence</strong> and<strong> Prevalence:</strong></p>\n<p>Prevalence depends upon <strong>incidence and duration</strong>.</p>\n<p><strong>Prevalence</strong> = <strong>Incidence x Mean Duration</strong></p>\n<p><strong>Longer the duration</strong> of the disease, the greater the prevalence.</p>\n<p>Few examples:</p>\n<ul>\n<li>In acute diseases, because of rapid recovery/death prevalence will be relatively <strong>lower</strong> than incidence. This is because, in some diseases (eg. food poisoning), the disease is so short-lived, there are no \"old cases\".</li>\n<li>In chronic diseases like TB, prevalence will be <strong>higher</strong> than incidence.</li>\n<li>If a new treatment for a disease is effective, incidence does not change but <strong>prevalence decreases</strong> as the duration of disease decreases.</li>\n<li>If the treatment only prevents death but doesn’t cure the disease, it may cause a <strong>paradoxical increase</strong> in prevalence.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8488",
      "difficulty": "easy"
    },
    {
      "text": "A patient with leprosy, who has completed a course of multi-drug therapy, presents with complaints of developing painful, tender, and raised lesions on his forehead recently as shown in the image below. What is the first-line treatment for him?",
      "choices": [
        {
          "id": 1,
          "text": "Restart multi drug therapy and start thalidomide"
        },
        {
          "id": 2,
          "text": "Restart multi drug therapy and start prednisolone"
        },
        {
          "id": 3,
          "text": "Start on clofazimine only"
        },
        {
          "id": 4,
          "text": "Start on prednisolone only"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The presence of <strong>new</strong> <strong>erythematous</strong> and <strong>tender</strong> subcutaneous <strong>nodules</strong> in a patient with leprosy indicates that he has developed <strong>type II lepra reaction. </strong>It is also known as <strong>Erythema Nodosum Leprosum (ENL) </strong>and the first line of treatment is <strong>prednisolone</strong>.</p>\n<p>Multi-drug therapy <strong>(MDT) should not be restarted</strong> in patients who develop lepra reactions after the completion of treatment.</p>\n<p>Prednisolone is started at a dose of 40 mg per day and gradually tapered by 5 mg every 2 weeks. 'Prednisolone card' is given when treatment is started. If the patient becomes <strong>steroid-dependent</strong>, then <strong>clofazimine</strong> is added.</p>\n<p>The <strong> key targets</strong> of the Global Leprosy Strategy <strong>2021-2023</strong> announced by WHO (Accelerating towards a leprosy-free world) are:</p>\n<ul>\n<li>120 countries reporting zero new autochthonous cases.</li>\n<li>70% reduction in the annual number of new cases detected.</li>\n<li>90% reduction in rate per million population of new cases with Grade 2 disability.</li>\n<li>90% reduction in rate per million children of new child cases with leprosy.</li>\n</ul>\n<p>The current goal is the elimination of leprosy. </p><hr><h3>Related Pearl: Lepra Reactions</h3><p><strong>Lepra Reactions:</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Type 1 Reaction</strong></p>\n<p>(Reversal/Upgrading)</p>\n</td>\n<td>\n<p><strong>Type 2 Reaction</strong></p>\n<p>(Erythema Nodosum Leprosum)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mainly seen in the&nbsp;<strong>Borderline</strong> spectrum (BT, BB, BL)</p>\n<p><strong>Most severe</strong> in Borderline Lepromatous(BL) leprosy</p>\n</td>\n<td>Mainly seen in <strong>LL</strong>(50%)&gt;BL(15%)</td>\n</tr>\n<tr>\n<td>\n<p>Usually seen <strong>within 12 months</strong> of initiation of Multidrug Therapy</p>\n</td>\n<td><strong>Unrelated</strong> to Multidrug therapy. May occur before, during or after treatment</td>\n</tr>\n<tr>\n<td>\n<p><strong>Type 4</strong> Hypersensitivity</p>\n<p>Due to <strong>enhanced cell-mediated response</strong>&nbsp;increased destruction of bacilli following treatment in reversal</p>\n</td>\n<td>\n<p><strong>Type 3</strong> Hypersensitivity</p>\n<p>Primarily Humoral</p>\n<p>(<strong>Immune complex Deposition</strong> in tissues and vessels)</p>\n<p>Cytokine involved - <strong>TNF-&alpha;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Inflammation of <strong>existing skin lesions</strong> (red, painful edematous skin lesions) that may <strong>ulcerate</strong></p>\n<p>New lesions may occur (rare)</p>\n<p><strong>Neuritis</strong>&nbsp;and <strong>Nerve abscesses&nbsp;</strong>(red, painful inflamed nerves)</p>\n</td>\n<td>\n<p><strong>New, erythematous and tender</strong>, subcutaneous and dermal nodules that are widely distributed over extremities and face</p>\n<p>Existing lesions do not change</p>\n</td>\n</tr>\n<tr>\n<td><strong>No</strong> systemic involvement</td>\n<td><strong>Systemic symptoms</strong> present - fever, myalgias, arthralgias, anorexia, keratitis, iritis, nephritis, synovitis, orchitis, lymphadenopathy</td>\n</tr>\n<tr>\n<td>\n<p><strong>Treatment:</strong></p>\n<p>Supportive therapy for mild reactions with <strong>NSAIDs</strong></p>\n<p>In case of severe reactions with neuritis and eye lesions- <strong>Oral corticosteroids</strong></p>\n<p><strong>(Drug of Choice)</strong></p>\n<p>Nerve Abscess - Additional <strong>surgical drainage</strong></p>\n<p>Other drugs: Clofazimine, Cyclosporine</p>\n</td>\n<td>\n<p><strong>Treatment:</strong></p>\n<p><strong>Oral Corticosteroids - First-line drug<br /><br />Clofazimine </strong>(Steroid dependent ENL)<strong><br /></strong></p>\n<p><strong>Thalidomide -most effective </strong>but not used first due to various side effects</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/72150c3fc1eb478f82fd07f89f059d6f.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4591",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following water-associated diseases is wrongly matched?",
      "choices": [
        {
          "id": 1,
          "text": "Water-borne disease - Typhoid"
        },
        {
          "id": 2,
          "text": "Water-based disease - Schistosomiasis"
        },
        {
          "id": 3,
          "text": "Water-washed disease - Cholera"
        },
        {
          "id": 4,
          "text": "Water-related vector-borne disease - Malaria"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Cholera </strong>is a <strong>water-borne</strong> disease.</p>\n<p>Water-related diseases are classified as:</p>\n<table>\n<tbody>\n<tr>\n<td>Category</td>\n<td>\n<p>Examples</p>\n</td>\n</tr>\n<tr>\n<td><strong>Water-borne diseases</strong></td>\n<td>\n<p>Caused by ingestion of water contaminated by human or animal feces, or urine containing pathogenic bacteria or viruses</p>\n<p>e.g.: <strong>Cholera</strong>, <strong>typhoid</strong>, amebic and bacillary dysentery, and other diarrheal diseases</p>\n</td>\n</tr>\n<tr>\n<td><strong>Water-washed diseases</strong></td>\n<td>\n<p>Caused by <strong>poor personal hygiene</strong></p>\n<p>e.g.: <strong>Scabies; trachoma;</strong> flea-, lice- and tick-borne diseases, in addition to the majority of water-borne diseases (which are also water-washed)</p>\n</td>\n</tr>\n<tr>\n<td><strong>Water-based diseases</strong></td>\n<td>\n<p>Caused by <strong>parasites</strong> found in intermediate organisms living in water</p>\n<p>e.g.: <strong>Dracunculiasis</strong>, <strong>schistosomiasis,</strong> and some other helminths.</p>\n<p> </p>\n</td>\n</tr>\n<tr>\n<td><strong>Water-related vector-borne diseases </strong></td>\n<td>\n<p>Caused by vectors that breed in water</p>\n<p>e.g.: <strong>Dengue,</strong> <strong>filariasis</strong>, <strong>malaria</strong>, onchocerciasis, trypanosomiasis and yellow fever</p>\n<p> </p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7035",
      "difficulty": "medium"
    },
    {
      "text": "You are volunteering in a vaccination camp. You perform a shake test before administering a particular vaccine. Which of the following is checked by this test?",
      "choices": [
        {
          "id": 1,
          "text": "Freeze damage to vaccine"
        },
        {
          "id": 2,
          "text": "Contamination of vaccine"
        },
        {
          "id": 3,
          "text": "Expiry of vaccine"
        },
        {
          "id": 4,
          "text": "Potency of vaccine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong>shake test</strong> is done to check for <strong>damage</strong> to vaccines that are sensitive to <strong>freezing temperatures.</strong></p>\n<p>Steps to perform the shake test:</p>\n<ul>\n<li>A <strong>frozen vaccine</strong> is used as a <strong>control vial</strong> and the vial suspected to be damaged by freezing is taken as the test vial.</li>\n<li>Both are <strong>shaken after thawing</strong> and the rate of <strong>sedimentation</strong> is <strong>compared</strong>.</li>\n<li>If the rate of <strong>sedimentation</strong> in the test vial is <strong>slower than</strong> that in the <strong>control</strong> vial, then it is <strong>usable</strong> and has not been damaged.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8e1d7fcab7b4460aa9557ded706a8a0dx600x796.JPEG\" alt=\"Explanation Image\"><p>Some of the most widely used&nbsp;<strong>vaccines</strong>&nbsp;are<strong>&nbsp;freeze-sensitive</strong>. These include vaccines against:</p>\n<ul>\n<li>Diphtheria</li>\n<li>Tetanus</li>\n<li>Pertussis</li>\n<li><em>Haemophilus influenza</em> type b (Liquid )</li>\n<li>Hepatitis B</li>\n</ul><hr><h3>Related Pearl: Temperature Sensitivity of Vaccines</h3><p><strong>Heat sensitivity</strong> in order of <strong>decreasing</strong> sensitivity:&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>Group</td>\n<td>Vaccines</td>\n</tr>\n<tr>\n<td>A</td>\n<td>OPV</td>\n</tr>\n<tr>\n<td>B</td>\n<td>Influenza</td>\n</tr>\n<tr>\n<td>C</td>\n<td>\n<p>IPV</p>\n<p>Japanese encephalitis(live)</p>\n<p>Measles, mumps, rubella</p>\n</td>\n</tr>\n<tr>\n<td>D</td>\n<td>\n<p>Cholera</p>\n<p>DTaP</p>\n<p>Pentavalent</p>\n<p>Rotavirus</p>\n<p>Hib(liquid)</p>\n<p>Yellow fever</p>\n<p>Measles</p>\n<p>Rubella</p>\n</td>\n</tr>\n<tr>\n<td>E</td>\n<td>\n<p>BCG</p>\n<p>HPV</p>\n<p>Japanese encephalitis(inactivated)</p>\n<p>Tetanus, TD, Td</p>\n</td>\n</tr>\n<tr>\n<td>F</td>\n<td>\n<p>Hepatitis B</p>\n<p>Hib(freeze-dried)</p>\n<p>Meningococcal A</p>\n<p>Pneumococcal</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Vaccine <strong>sensitivity to freezing</strong>:</p>\n<p><strong>Rotavirus(liquid)</strong>&lt; T,DT,dT&lt; IPV &lt; Hib(liquid)&lt; HepB &lt; Pentavalent &lt;<strong>DTaP</strong></p>\n<p>Vaccines not damaged by freezing:</p>\n<ul>\n<li>Yellow fever</li>\n<li>BCG</li>\n<li>Hib</li>\n<li>Japanese encephalitis(live and inactivated)</li>\n<li>Measles, mumps, rubella</li>\n<li>OPV</li>\n<li>Rabies</li>\n<li>Rotavirus(Freeze-dried)</li>\n<li>Varicella zoster</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c7bd80ca927b42bcb0956bc12ae146b7x956x717.PNG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9482",
      "difficulty": "easy"
    },
    {
      "text": "RDA of calcium for pregnant and breastfeeding mothers are, respectively:",
      "choices": [
        {
          "id": 1,
          "text": "1000 mg and 1000 mg"
        },
        {
          "id": 2,
          "text": "1000 mg and 1200 mg"
        },
        {
          "id": 3,
          "text": "1200 mg and 1200 mg"
        },
        {
          "id": 4,
          "text": "1200 mg and 1000 mg"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>According to the <strong>RDA 2020 guideline</strong>,&nbsp;RDA of calcium for pregnant and breastfeeding mothers are&nbsp;1000 mg and 1200 mg, respectively.</p><hr><h3>Related Pearl: Recommended Dietary Allowances For Energy And Protein For Indians</h3><table>\n<tbody>\n<tr>\n<td> </td>\n<td><strong>Category</strong></td>\n<td><strong>EAR - Energy(Kcal/D) </strong></td>\n<td><strong> RDA - Protein (g/D) </strong></td>\n</tr>\n<tr>\n<td>Man</td>\n<td>\n<ul>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\">Sedentary work </li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\">Moderate work </li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">Heavy work  </li>\n</ul>\n</td>\n<td>\n<ul>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\">2110 </li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\">2710 </li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">3470 </li>\n</ul>\n</td>\n<td>\n<ul>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\">54</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\">54</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">54</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Woman </td>\n<td>\n<ul>\n<li>Sedentary work </li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\">Moderate work </li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">Heavy work </li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"4\" data-aria-level=\"1\">Pregnancy <br /><br /><br /></li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"5\" data-aria-level=\"1\">Lactation (0-6m) </li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"6\" data-aria-level=\"1\">Lactation (6-12m) </li>\n</ul>\n</td>\n<td>\n<ul>\n<li>1660</li>\n<li>2130</li>\n<li>2720 </li>\n<li>+340 (2nd trimester)<br />+452 (3rd trimester)</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"5\" data-aria-level=\"1\">+600 </li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"6\" data-aria-level=\"1\">+520 </li>\n</ul>\n</td>\n<td>\n<ul>\n<li>46</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\">46</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">46</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">+9.5(2nd trimester)<br />+22 (3rd trimester)<br /><br /></li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"5\" data-aria-level=\"1\">+17  </li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"6\" data-aria-level=\"1\">+13 </li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Infant</td>\n<td>\n<ul>\n<li>0-6 months</li>\n<li>6-12 months</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>530</li>\n<li>660</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>8.0</li>\n<li>10.5</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Dietary Reference Intakes</strong></p>\n<ul>\n<li>Recommended Dietary Allowance (RDA) - The average daily dietary intake that is sufficient to meet the requirements of almost all individuals in a group</li>\n<li>Estimated Average Requirement (EAR) - A nutrient intake value that is estimated to meet the requirements of half the individuals in a group</li>\n</ul>\n<p>The EAR for an <strong>elderly male </strong>(&gt;60 years) is <strong>1700 Kcal/D</strong> and for an <strong>elderly female </strong>(&gt;60 years) is <strong>1500 Kcal/D</strong>.</p>\n<p>Note: There is no RDA for energy. The EAR is equivalent to Estimated Energy Requirement (EER).</p><hr><h3>Related Pearl: RDA Of Important Minerals</h3><p>These values are specific for the <strong>Recommended Daily Allowances (RDA)</strong>:</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;&nbsp; <strong>Mineral</strong></td>\n<td><strong>Recommended intake (per day)</strong></td>\n</tr>\n<tr>\n<td>Folic acid&nbsp;\n<ul>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"21\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\">Children</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"21\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\">Adult male</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"21\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\">Adult female&nbsp;</li>\n<li>Pregnancy</li>\n<li>Lactation&nbsp;&nbsp;&nbsp;</li>\n</ul>\n</td>\n<td>\n<p>&nbsp;</p>\n<ul>\n<li>120-170 mcg&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"21\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\">300 mcg</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"21\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\">220 mcg</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"21\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">570 mcg&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"21\" aria-setsize=\"-1\" data-aria-posinset=\"4\" data-aria-level=\"1\">330 mcg&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Iron&nbsp;\n<ul>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"25\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\">Adult male&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"25\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\">Adult female&nbsp;&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"25\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">Pregnancy&nbsp;&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"25\" aria-setsize=\"-1\" data-aria-posinset=\"4\" data-aria-level=\"1\">Lactation&nbsp;&nbsp;</li>\n</ul>\n</td>\n<td>&nbsp;\n<ul>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"25\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\">19 mg&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"25\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\">29 mg&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"25\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">27 mg&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"25\" aria-setsize=\"-1\" data-aria-posinset=\"4\" data-aria-level=\"1\">23 mg&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Calcium&nbsp;\n<ul>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"48\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\">Adult male&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"48\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\">Adult female&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"48\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">Pregnancy&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"48\" aria-setsize=\"-1\" data-aria-posinset=\"4\" data-aria-level=\"1\">Lactation&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"48\" aria-setsize=\"-1\" data-aria-posinset=\"4\" data-aria-level=\"1\">Elderly</li>\n</ul>\n</td>\n<td>&nbsp;\n<ul>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"48\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\">1000 mg&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"48\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\">1000 mg&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"48\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">1000 mg&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"48\" aria-setsize=\"-1\" data-aria-posinset=\"4\" data-aria-level=\"1\">1200 mg&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"48\" aria-setsize=\"-1\" data-aria-posinset=\"4\" data-aria-level=\"1\">1200 mg</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Iodine</p>\n<ul>\n<li>Infant(0- 6m)</li>\n<li>Infant(7&ndash;12m)</li>\n<li>Children (1-9yrs)</li>\n<li>Children (9-16yrs)</li>\n<li>Adult male</li>\n<li>Adult female</li>\n<li>Pregnancy</li>\n<li>Lactation&nbsp;</li>\n</ul>\n</td>\n<td>\n<p>&nbsp;</p>\n<ul>\n<li>100 mcg</li>\n<li>130 mcg</li>\n<li>90-120 mcg</li>\n<li>150 mcg</li>\n<li>150 mcg</li>\n<li>150 mcg</li>\n<li>250 mcg</li>\n<li>280 mcg&nbsp;</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Mineral</strong></td>\n<td>\n<p><strong>Recommended intake</strong></p>\n<p><strong> (per day)</strong></p>\n</td>\n</tr>\n<tr>\n<td>Phosphorous&nbsp;</td>\n<td>1000 mg</td>\n</tr>\n<tr>\n<td>Sodium&nbsp;</td>\n<td>2000 mg</td>\n</tr>\n<tr>\n<td>Potassium&nbsp;</td>\n<td>3500 mg&nbsp;</td>\n</tr>\n<tr>\n<td>Copper&nbsp;</td>\n<td>2 mg</td>\n</tr>\n<tr>\n<td>Manganese&nbsp;</td>\n<td>4 mg</td>\n</tr>\n<tr>\n<td>Chromium&nbsp;</td>\n<td>50 mcg</td>\n</tr>\n<tr>\n<td>Selenium</td>\n<td>40 mcg</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF6558",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following are elements of primary healthcare?<div class='question-desc-html'><ol>\n<li>Adequate supply of safe water and basic sanitation</li>\n<li>Provision of essential drugs</li>\n<li>Prevention of locally endemic diseases</li>\n<li>Use of appropriate technology</li>\n<li>Ensure community participation</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "2, 3, 4"
        },
        {
          "id": 2,
          "text": "1, 3, 5"
        },
        {
          "id": 3,
          "text": "1, 2, 3"
        },
        {
          "id": 4,
          "text": "1, 4, 5"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The <strong>elements of primary health care</strong> include:</p>\n<ol>\n<li>Adequate supply of safe water and basic sanitation</li>\n<li>Providing essential drugs</li>\n<li>Prevention of locally endemic diseases</li>\n</ol>\n<p>Primary health care refers to essential health care that is universally available to individuals, acceptable to them through their full participation, and at a cost the community and country can afford.</p>\n<p>The use of appropriate technology and ensuring community participation are <strong>p</strong><strong>rinciples/pillars of Primary Health Care.</strong></p><hr><h3>Related Pearl: Elements and Principles of Primary Health Care</h3><p><strong>A. Elements of Primary Health Care</strong></p>\n<p>(Mnemonic: <strong>ELEMENTS</strong>)</p>\n<ul>\n<li><strong>E</strong>ducation about health problems and their prevention and control</li>\n<li><strong>L</strong>ocally endemic diseases &ndash; prevention and control</li>\n<li><strong>E</strong>ssential drugs</li>\n<li><strong>M</strong>aternal and child health care</li>\n<li><strong>E</strong>xpanded programme of immunization against vaccine preventable diseases</li>\n<li><strong>N</strong>utrition and proper food supply</li>\n<li><strong>T</strong>reatment of common diseases and injuries</li>\n<li><strong>S</strong>afe water and sanitation</li>\n</ul>\n<p><strong>B. Principles/Pillars of Primary Health Care</strong></p>\n<ul>\n<li>Equitable distribution</li>\n<li>Community participation</li>\n<li>Intersectoral coordination</li>\n<li>Appropriate technology</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8461",
      "difficulty": "medium"
    },
    {
      "text": "How does the insecticide derived from the given plant kill the insects?",
      "choices": [
        {
          "id": 1,
          "text": "Its a nerve poison, it kils insects on mere contact"
        },
        {
          "id": 2,
          "text": "Its a stomach poison, it kills the insects after ingestion"
        },
        {
          "id": 3,
          "text": "It repels the insects for 18-20 hours"
        },
        {
          "id": 4,
          "text": "It cuts off the air supply of the insects/larvae and kills"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given plant is <strong>pyrethrum(Chrysanthemum cinerariafolium)</strong>, the extract from the <strong>flowers</strong> contains <strong>pyrethrin</strong> which is a&nbsp;<strong>nerve poison,</strong> which kills insects merely <strong>on contact.</strong></p>\n<p>Pyrethrum is used as <strong>space sprays,</strong> sprayed into the atmosphere in the form of <strong>fog or mist</strong> to kill the insects. These effectively reduce the number of mosquitoes but the effect is temporary as it has<strong> no residual action.</strong> Reinfestation can occur soon from other areas.</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Insecticides</h3><p><strong>Contact poisons</strong></p>\n<ul>\n<li><strong>Natural</strong>: Pyrethrum, rotenone, derris, nicotine, mineral oils</li>\n<li><strong>Synthetic:</strong>\n<ul>\n<li><strong>Organo-chlorine compounds</strong>: DDT, methoxychlor, HCH, lindane, chlordane, heptachlor, dieldrin, aldrin, toxaphene, kepone, mirex.</li>\n<li><strong>Repellants</strong>: Benzyl benzoate, indalone, meta-diethyltoluamide, dimethyl phthalate, ethyl hexanediol.</li>\n<li><strong>Organo-phosphorus compounds</strong>: Chlorthion (aryl), diazinon (aryl), demethoate, malathion (alkyl), fenthion, parathion (aryl), trichlorfon (alkyl), runnel, abale, naled, chlorpyrifos, fenitrothion, dicapthon.</li>\n<li><strong>Carbamates</strong>: Carbaryl, dimetilan, propoxur, pyrolan.</li>\n<li><strong>Synthetic pyrethroids</strong>: Prothrin, resmethrin, bioresmethrin, permethrin, proparthin, tetramethrin</li>\n</ul>\n</li>\n<li><strong>Stomach poisons</strong>: Paris green, sodium fluoride.</li>\n<li><strong>Fumigants</strong>: Hydrogen cyanide, methyl bromide, sulphur dioxide, carbon disulphide.</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>Specific Insecticides</strong></td>\n<td><strong>Comments</strong></td>\n</tr>\n<tr>\n<td><strong>DDT </strong>(Dichloro-diphenyl-thrichloroethane)</td>\n<td>Insecticidal properties were discovered by Swiss scientist, <strong>Paul Muller</strong>. Most widely used insecticide. Attacks nerves of insects but doesn&rsquo;t cause immediate death. White amorphous powder. Contains 70 &ndash; 80% of <strong>para-para isomers</strong>, which is the most active fraction of DDT. Has residual action up to 18 months. Used as a <strong>residual spray</strong>.Least toxic organo-chlorine compound.</td>\n</tr>\n<tr>\n<td><strong>HCH</strong> (hexachlorocyclo-hexane)</td>\n<td>Synthesized by <strong>Michael Faraday.</strong> Normal HCH contains 13 &ndash; 16% of gamma isomer. Gamma-HCH or <strong>lindane</strong> has 99% gamma isomer.Short residual action &ndash; 3 months.</td>\n</tr>\n<tr>\n<td><strong>Malathion</strong></td>\n<td><strong>Least toxicity</strong> of all <strong>organophosphorus</strong> compounds. Used as an <strong>ultra-low volume spray.</strong></td>\n</tr>\n<tr>\n<td><strong>Fenthion</strong></td>\n<td>Also called <strong>baytex.</strong> Used as a <strong>residual spray</strong>.</td>\n</tr>\n<tr>\n<td><strong>Pyrethrum</strong></td>\n<td>Vegetable origin &ndash; <strong>Chrysanthemum cinerariafolium.</strong> Nerve poison and is excellent as a <strong>space spray.</strong>No residual action.Synergistic action with DDT as space spray.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/b03dfdfd16b748d28e4c33a01fa4f7f8.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD5018",
      "difficulty": "medium"
    },
    {
      "text": "A cardiologist wants to study the effect of the atorvastatin drug. She measures the initial cholesterol levels of 50 patients. After a month's treatment, she measures the cholesterol level again. Which of the following tests will she use to test the statistical significance of the change in the cholesterol level?",
      "choices": [
        {
          "id": 1,
          "text": "Paired t test"
        },
        {
          "id": 2,
          "text": "Unpaired t test"
        },
        {
          "id": 3,
          "text": "ANOVA"
        },
        {
          "id": 4,
          "text": "Chi-square test"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In this scenario, the <strong>variable</strong> (cholesterol level) is <strong>quantitative.&nbsp;</strong>Moreover, the <strong>comparison</strong> is being done <strong>before</strong> and <strong>after</strong> the <strong>treatment</strong>&nbsp;(dependent)<strong>.</strong>&nbsp;Hence, a&nbsp;<strong>paired t test</strong>&nbsp;will be used.</p><hr><h3>Related Pearl: Tests of Significance</h3><p><strong>How to choose which test to use?</strong></p>\n<ul>\n<li>See the <strong>variable</strong>. Are the variables <strong>quantitative</strong> or <strong>qualitative</strong>?\n<ul>\n<li>If the variables are <strong>qualitative&nbsp;</strong>(<strong>nominal</strong>), then <strong>Chi square test</strong> is used.</li>\n<li>If the variables are <strong>quantitative</strong>, then see whether <strong>2 groups or more than 2 groups&nbsp;</strong>.\n<ul>\n<li>If <strong>2 groups </strong>are being tested, then <strong>T tests</strong> are used. In that, if the same group is tested before and after, paired T test is used. Otherwise, unpaired T test is used.</li>\n<li>If <strong>more than 2 groups</strong> are being tested, then use <strong>ANOVA</strong>.</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul>\n<p><strong>1. T Tests</strong></p>\n<ul>\n<li><strong>Unpaired t tests</strong>\n<ul>\n<li>Also known as the <strong>student&rsquo;s t test, independent t test, two-samples t test</strong>.</li>\n<li>It's the <strong>most commonly used t test</strong>&nbsp;and it tests the difference between two groups (the means of 2 groups)<strong> independent</strong> of each other<strong>&nbsp;</strong>and indicates how significant the differences are<strong>.</strong></li>\n</ul>\n</li>\n<li><strong>Paired t tests</strong>\n<ul>\n<li>\"Pairs <strong>before</strong>&nbsp;marriage are not the same <strong>after!\"</strong></li>\n<li>So remember the&nbsp;<strong>paired</strong> test is mainly used in the comparison of a&nbsp;<strong>before and after scenario</strong>&nbsp;</li>\n<li>Also known as<strong> correlated t test,</strong>&nbsp;<strong>dependent samples t test</strong>.</li>\n<li>It is mainly used on dependent samples.<strong>&nbsp;</strong>For example, the cholesterol level of a person before and after using a specific drug.</li>\n<li>It can also be used when you put the <strong>same condition</strong> under <strong>test</strong> <strong>using different items</strong> or things. For example, same crash safety tests for different cars.</li>\n</ul>\n</li>\n<li><strong>T scores</strong>&nbsp;\n<ul>\n<li>The t score is referred to as the <strong>ratio </strong>of<strong>&nbsp;</strong>the difference between two groups and the difference within the groups.</li>\n<li>The <strong>smaller </strong>the t score, the <strong>more similarity</strong> there is between two groups and vice versa.</li>\n</ul>\n</li>\n</ul>\n<p>&nbsp;</p>\n<p><strong>2</strong>. <strong>Analysis of Variance (ANOVA)</strong></p>\n<ul>\n<li>The analysis of variance test (<strong>ANOVA)</strong> is used to test the difference between two or usually<strong> more than two groups (means) </strong>and here the inferences are made by analyzing the variances.</li>\n</ul>\n<p>&nbsp;</p>\n<p><strong>3</strong>. <strong>Chi-Square Test</strong></p>\n<ul>\n<li>The <strong>Chi-Square test (&chi;<sup>2</sup>)</strong> is a <strong>non-parametric(non-numeric) test</strong> and it is used to test hypotheses in relation to <strong>nominal scale data or categorical data.</strong></li>\n<li>It is a <strong>test of proportions and associations.</strong></li>\n<li>A Chi-square distribution is usually<strong> positively skewed</strong> but it approaches a normal distribution as its degrees of freedom increases.</li>\n<li>If the <strong>frequency of any of the cells of the categorical table</strong> is&nbsp;<strong>&lt;5</strong>, then&nbsp;<strong>Fisher&rsquo;s exact test</strong> is used.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2749",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is the most universally accepted health status indicator?",
      "choices": [
        {
          "id": 1,
          "text": "IMR"
        },
        {
          "id": 2,
          "text": "MMR"
        },
        {
          "id": 3,
          "text": "Life expectancy"
        },
        {
          "id": 4,
          "text": "NMR"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Infant mortality rate</strong> (IMR) is the most <strong>universally accepted </strong>health status indicator of the whole population and of the socio-economic conditions in which they live.</p>\n<p>Infant mortality rate (IMR)= Number of deaths in the first year of life/Number of live births x 1000</p>\n<p>It is a <strong>sensitive indicator of</strong> the availability, utilisation, and effectiveness of <strong>health care</strong>. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2699",
      "difficulty": "easy"
    },
    {
      "text": "The following diagram charts the population change over years from 1983 to 1989 in a given place. What is the statistical diagram used here?",
      "choices": [
        {
          "id": 1,
          "text": "Histogram"
        },
        {
          "id": 2,
          "text": "Line diagram"
        },
        {
          "id": 3,
          "text": "Component bar graph"
        },
        {
          "id": 4,
          "text": "Multiple bar graphs"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given image shows a&nbsp;<strong>component bar graph.&nbsp;</strong>It is&nbsp;used to represent data in which the<strong> total magnitude</strong> is<strong> divided into </strong>different subsets or<strong> components.</strong></p>\n<p>A<strong> bar chart&nbsp;</strong>or bar graph is used mainly for<strong> nominal</strong> or <strong>ordinal scale</strong> data. They can be simple, multiple or component bar graphs.</p>\n<p>The image given below shows a <strong>multiple bar graph&nbsp;</strong>showing the human losses of world war II by country. In a multiple bar chart,&nbsp;<strong>2 or more sets of data</strong> are shown <strong>simultaneously</strong>.&nbsp;&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/cdb62d9d756f4238b5f103941d61c2c6x524x519.PNG\" alt=\"Explanation Image\"><p>A <strong>bar chart&nbsp;</strong>can be distinguished from a histogram<strong>&nbsp;</strong>because the <strong>rectangles</strong>&nbsp;are <strong>separated&nbsp;by</strong> the <strong>spaces</strong>. This indicates that the data forms&nbsp;<strong>discrete categories</strong>.</p>\n<p>In a <strong>histogram</strong>, the <strong>rectangles</strong> are <strong>not separated</strong> by spaces as the data represented forms a&nbsp;<strong>continuous&nbsp;set</strong>&nbsp;instead of discrete groups.</p><hr><h3>Related Pearl: Graphical Representation of Data</h3><p>1.<strong> Histogram</strong></p>\n<ul>\n<li>A histogram, by definition, is a <strong>graphical representation </strong>of frequency distribution that contains rectangles and shows the underlying <strong>frequency</strong> of a set of <strong>continuous,</strong> <strong>quantitative data.</strong></li>\n<li>The <strong>X or horizontal axis</strong> is called the <strong>abscissa</strong> which usually has the group scores or class intervals of the variables/data and the <strong>Y or vertical axis</strong> is called the <strong>ordinate</strong> which usually shows the <strong>frequencies </strong>at which these variables appear.</li>\n<li>The following image shows a histogram.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4a7878d951f54990a67a0c8de11a1bb7x563x438.PNG\" alt=\"Pearl Image\"><p>2. <strong>Bar Chart</strong></p>\n<ul>\n<li>It is also called a <strong>bar graph.</strong></li>\n<li>It is used mainly for <strong>nominal or ordinal scale data</strong> as they are not quantitative and usually <strong>qualitative</strong>.</li>\n<li>The difference between a bar graph and a histogram is that the rectangles are separated by spaces representing data that forms <strong>discrete categories</strong> instead of continuous groups.</li>\n<li>Bar graphs can be <strong>simple, multiple or component</strong> bar graphs.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8f58ed9550a74b54a669177f5cf4d95ex320x320.PNG\" alt=\"Pearl Image\"><p><strong>3. Pie Charts</strong></p>\n<ul>\n<li>Pie charts are also used for <strong>nominal or ordinal data.</strong></li>\n<li>The categorical data are represented as <strong>segments of a circle.</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/50e3eef6a816413fa1848c834d7bad36x556x516.JPEG\" alt=\"Pearl Image\"><p><strong>4. Frequency polygons</strong></p>\n<ul>\n<li>Frequency polygons are used for mainly ratio and interval scale data.</li>\n<li>In a frequency polygon, the mid-points of each class interval are joined together by straight lines.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/094f9b92f79940e4a3f57c4f9a732b58x590x424.PNG\" alt=\"Pearl Image\"><p><strong>5. Ogive</strong></p>\n<ul>\n<li>A frequency polygon which is drawn to represent cumulative frequency distributions form a typical S-shaped curve which is called an ogive. It referred to as a cumulative frequency diagram.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5444b851ed95409bb25a180767a73d91x1280x740.PNG\" alt=\"Pearl Image\"><p><strong>6. Line chart</strong></p>\n<ul>\n<li>It is also called a <strong>line diagram or line graph.</strong></li>\n<li>Its best use is to show the <strong>trend of events</strong> or <strong>change over passage of time</strong>.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/515d36ccf06c4781960d8bc846ce5063x412x430.PNG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/9fb633302d514883b7d7f79ebfbcd8be.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7444",
      "difficulty": "easy"
    },
    {
      "text": "Sample sizes of samples 1, 2 and 3 are 1000, 800, 600 respectively. The order of margin of error will be ____________.",
      "choices": [
        {
          "id": 1,
          "text": "3 >2>1"
        },
        {
          "id": 2,
          "text": "3>1>2"
        },
        {
          "id": 3,
          "text": "1>2>3"
        },
        {
          "id": 4,
          "text": "1=2=3"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Curve 1 has the least margin of error, followed by curve 2, and then curve 3. So the order is<strong> 3&gt;2&gt;1.</strong></p>\n<p>The image shows three normal distribution curves of different sample sizes, having the same mean but different standard deviations.</p>\n<p>As the sample size is decreasing, the peak decreases and the curve becomes more flat, implying a wider confidence of interval for the given mean.</p>\n<p>The <strong>width of the base</strong> of the curve is <strong>directly proportional to the margin of error.</strong> </p><hr><h3>Related Pearl: Normal Distribution</h3><p><strong>The normal distribution </strong>curve is the most <strong>common </strong>shape taken by<strong> continuous data </strong>distributions. It is also called <strong>bell curve </strong>(bell-shaped) or <strong>Gaussian distribution</strong> after mathematician Karl Friedrich Gauss.</p>\n<p>The following is an image of three different normal distribution curves.</p><img src=\"https://cdn1.dailyrounds.org/uploads/99fb903f13594e838e63dcee222ccc82x479x387.JPEG\" alt=\"Pearl Image\"><p>Salient features of the&nbsp;<strong>standard normal distribution</strong>:</p>\n<ul>\n<li>Defined by two parameters:&nbsp;the<strong>&nbsp;mean&nbsp;</strong>and the&nbsp;<strong>standard deviation</strong></li>\n<li>Has<strong> mean</strong> of<strong> 0</strong> and a<strong> standard deviation</strong> of<strong> 1</strong></li>\n<li><strong>Mean = median = mode</strong></li>\n<li><strong>Symmetric</strong>&nbsp;and have&nbsp;<strong>bell</strong>-shaped <strong>curves</strong>&nbsp;with a single peak</li>\n<li>Total<strong> area under the curve </strong>is<strong> 1</strong></li>\n<li><strong>Frequency of values</strong>&nbsp;is <strong>more around the center</strong> and <strong>less around the tails</strong></li>\n<li><strong>No skew </strong>in the curve</li>\n<li>Data like blood pressure, heights, IQ scores, etc. form a normal distribution</li>\n<li>The <strong>empirical rule</strong> of a normal distribution:\n<ul>\n<li>Approximately <strong>68%</strong> of the distribution falls within <strong>one</strong> standard deviation of the mean (<strong>mean &plusmn; 1 SD</strong>)</li>\n<li>Approximately <strong>95%</strong> of the distribution falls within <strong>two </strong>standard deviations of the mean (<strong>mean &plusmn; 2 SD</strong>)</li>\n<li>Approximately <strong>99.7%</strong> of the distribution falls within <strong>three </strong>standard deviations of the mean (<strong>mean &plusmn; 3 SD</strong>)</li>\n</ul>\n</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9b2acfa7a0024a73895e0113ce912fbcx1280x1219.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/32951ed1cda941f3bd7484d8e8e30c62.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5218",
      "difficulty": "medium"
    },
    {
      "text": "According to National Urban Health Mission, arrange the following in the correct order as per population covered from lowest to the highest level.<div class='question-desc-html'><ol>\n<li>Urban Primary Health Centre</li>\n<li>Urban Community Health Centre</li>\n<li>Auxiliary Nurse Midwife </li>\n<li>Urban Social Health Activist</li>\n<li>Mahila Arogya Samiti</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "3 , 1 , 2 , 4 , 5"
        },
        {
          "id": 2,
          "text": "5 , 3 , 4 , 1 , 2"
        },
        {
          "id": 3,
          "text": "5 , 4 , 3 , 1 , 2"
        },
        {
          "id": 4,
          "text": "4 , 5 , 3 , 1 , 2"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The correct order from the primary level of contact with the community to the highest level is<strong> 5 &gt; 4 &gt; 3 &gt; 1 &gt; 2</strong> :</p>\n<ul>\n<li>Mahila Arogya Samiti - <strong>250-500</strong> population </li>\n<li>Urban Social Health Activist - <strong>2,500</strong> population</li>\n<li>Auxiliary Nurse Midwife - <strong>10,000</strong> population</li>\n<li>Urban Primary Health Centre - <strong>50,000</strong> population</li>\n<li>Urban Community Health Centre - <strong>2.5 lakh</strong> population. </li>\n</ul><hr><h3>Related Pearl: Suggested Norms for Health Workforce</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Health Personnel</strong></p>\n</td>\n<td>\n<p><strong>Norm Suggested</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Doctor</p>\n</td>\n<td>\n<p>1 per 1000 population</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Health worker (Male and female)</p>\n</td>\n<td>\n<p>1 per 5000 in plains</p>\n<p>1 per 3000 remote or hilly areas</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Health assistant (Male and female)</p>\n</td>\n<td>\n<p>1 per 30,000 in plains</p>\n<p>1 per 20,000 in remote or hilly areas</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pharmacist</p>\n</td>\n<td>\n<p>1 per 10,000</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lab technician</p>\n</td>\n<td>\n<p>1 per 10,000</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Auxillary Nurse Midwife</p>\n</td>\n<td>\n<p>1 per 10,000</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Urban Social Health Activist</p>\n</td>\n<td>\n<p>1 per 1000-2500</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Accredited Social Health Activist (ASHA)</p>\n</td>\n<td>\n<p>1 per 1000 (a village, 200-500 households)</p>\n<p>1 per habitation in remote or hilly areas</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Trained Dais or Trained Birth Attendant</p>\n</td>\n<td>\n<p>1 per 1000 (a village)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Village health guide (VHG)</p>\n</td>\n<td>\n<p>1 per 1000 (a village)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Anganwadi worker (AWW)</p>\n</td>\n<td>\n<p>1 per 400 to 800 in plains</p>\n<p>1 per 300 to 800 in remote or hilly areas</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nurse</p>\n</td>\n<td>\n<p>1 per 5000</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mahila Arogya Samiti</p>\n</td>\n<td>\n<p>1 per 250-500 (50-100 households)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8504",
      "difficulty": "medium"
    },
    {
      "text": "How efficacious is the hypochlorous acid, when compared to the hypochlorite ions in terms of its disinfecting action?",
      "choices": [
        {
          "id": 1,
          "text": "Similar effect"
        },
        {
          "id": 2,
          "text": "Around 70 times more effective"
        },
        {
          "id": 3,
          "text": "Around 10 times more effective"
        },
        {
          "id": 4,
          "text": "Less effect"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Hypochlorous acid </strong>is the most effective form of chlorine and it is <strong>almost 70 &ndash; 80 times more effective</strong> than hypochlorite ions.</p>\n<p>The disinfecting action of chlorine is predominantly due to <strong>hypochlorous acid</strong>.</p><hr><h3>Related Pearl: Chlorination of Water</h3><ul>\n<li>Chlorination is widely used for the&nbsp;<strong>large-scale purification</strong>&nbsp;of<strong>&nbsp;drinking water.</strong></li>\n<li>It is bactericidal and moderately virucidal but not <strong>sporicidal</strong>, except in high doses.</li>\n<li>It oxidizes<strong>&nbsp;iron, manganese, and hydrogen sulphide</strong>. It also destroys some taste and odour&nbsp;producing components. It <strong>controls algae and slime</strong> organisms and <strong>aids in coagulation</strong>.</li>\n<li><strong>The action of chlorine:</strong>\n<ul>\n<li><strong>Hydrochloric acid and hypochlorous acid </strong>are formed when chlorine is added to water. <strong>Hypochlorous acid</strong> ionizes to form <strong>hydrogen and hypochlorite ions.</strong></li>\n<li>H<sub>2</sub>O + Cl<sub>2</sub> &rarr; HCl + HOCl<br /> HOCl &rarr; H + OCl</li>\n<li>The disinfecting action of chlorine is predominantly due to <strong>hypochlorous acid</strong>. <strong>Hypochlorous acid</strong>&nbsp;is&nbsp;the most<strong>&nbsp;effective</strong> form of chlorine and it is <strong>almost 70 &ndash; 80 times</strong>&nbsp;more effective than<strong>&nbsp;hypochlorite ions</strong>.</li>\n<li>Chlorine acts best in <strong>water</strong> that has a <strong>pH of around 7</strong>.</li>\n</ul>\n</li>\n<li><strong>Principles of chlorination:</strong>\n<ul>\n<li>The water to be disinfected must be <strong>clear of turbidity</strong> as turbidity <strong>impedes efficient chlorination</strong>.</li>\n<li>The <strong>chlorine demand</strong> of water is the <strong>difference between the amount of chlorine added to the water</strong> and the <strong>amount of residual chlorine</strong> remaining at the end of a specific period of contact (usually 60 minutes) at a given temperature and pH of the water. This has to&nbsp;be estimated<strong> before&nbsp;</strong>chlorination is done.</li>\n<li>The <strong>point</strong>&nbsp;at which<strong>&nbsp;the chlorine demand </strong>of&nbsp;water&nbsp;is met is called the <strong>breakpoint</strong>. It is beyond this that<strong> residual free chlorine</strong> begins to appear.</li>\n<li><strong>Contact period</strong>&nbsp;of free chlorine for at least<strong>&nbsp;one hour</strong> is required to kill bacteria and viruses.</li>\n<li>&nbsp;<strong>Minimum recommended concentration</strong>&nbsp;of free chlorine is<strong>&nbsp;0.5 mg/litre</strong>&nbsp;for<strong>&nbsp;one hour</strong>. Free residual chlorine provides a margin of <strong>safety</strong> against <strong>microbial contamination</strong> that occurs in storage or transport.</li>\n<li>The <strong>sum</strong> of the <strong>chlorine demand</strong> of the specific water plus <strong>free residual chlorine</strong>&nbsp;of 0.5<strong> mg/litre</strong> constitutes the <strong>correct dose of chlorine</strong> to be applied.</li>\n</ul>\n</li>\n<li><strong>Methods of chlorination:</strong>\n<ul>\n<li><strong>Chlorine gas</strong>: It is the <strong>first choice</strong> as it is <strong>cheap, quick and efficient</strong> in action, and easy to apply. Special <strong>chlorinating equipments</strong> like <strong>Paterson&rsquo;s chloronome</strong> are used for the application of chlorine gas.</li>\n<li><strong>Chloramines</strong>: These<strong>&nbsp;loose compounds of chlorine and ammonia</strong> give more persistent forms of residual chlorine. They have <strong>slow action</strong> and thus are not widely used.</li>\n<li><strong>Perchloron</strong> or <strong>high test hypochlorite (H.T.H.)</strong>: It is a <strong>calcium compound</strong> that has <strong>60 &ndash; 70% of available chlorine</strong>.</li>\n</ul>\n</li>\n<li><strong>Break point chlorination:</strong>\n<ul>\n<li>The point at which the <strong>chlorine demand of water</strong>&nbsp;is met is called<strong>&nbsp;the breakpoint. </strong></li>\n<li><strong>Free chlorine</strong> (HOCl and OCl) appears when <strong>chlorine is added beyond the breakpoint</strong>.</li>\n<li>In other words, at the breakpoint, if chlorine is added, then <strong>all the combined chlorines</strong>&nbsp;would have been completely<strong>&nbsp;destroyed</strong> and <strong>free residual chlorines </strong>begin to&nbsp;<strong>appear</strong>.</li>\n<li>This corresponding dosage to achieve the appearance of free residual chlorine is called <strong>breakpoint dosage</strong> and this method is called <strong>breakpoint chlorination</strong>.</li>\n<li>It is also called <strong>controlled superchlorination</strong></li>\n<li><strong>Superchlorination </strong>followed by <strong>dechlorination </strong>is used to disinfect highly polluted waters whose quality fluctuates greatly.</li>\n</ul>\n</li>\n<li><strong>Orthotolidine (OT) test:</strong>\n<ul>\n<li>It is a <strong>test for chlorination</strong> and determines <strong>free and combined chlorine</strong> in water, rapidly and accurately.</li>\n<li>The reagent used is <strong>analytical grade Orthotolidine</strong> dissolved in a 10% solution of hydrochloric acid.</li>\n<li>When added to water that contains chlorine, it turns <strong>yellow</strong> with varying intensity. This is <strong>faster</strong> in the presence of <strong>free chlorine</strong> and <strong>slower</strong> in the presence of <strong>combined chlorine</strong>.</li>\n</ul>\n</li>\n<li><strong>Orthotolidine - arsenite (OTA) test:</strong>\n<ul>\n<li>This is a <strong>modification of the OT test</strong> which <strong>nullifies the errors</strong>&nbsp;due to interfering substances<strong>&nbsp;</strong>like <strong>iron, nitrites, manganese</strong>, etc.</li>\n<li>It determines <strong>free</strong>&nbsp;and<strong>&nbsp;combined chlorine separately.</strong></li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3998",
      "difficulty": "medium"
    },
    {
      "text": "A group of health workers is conducting a perinatal mortality audit at a hospital. Which of the following should they not take into account to calculate the perinatal mortality rate?",
      "choices": [
        {
          "id": 1,
          "text": "Number of live births per year"
        },
        {
          "id": 2,
          "text": "Number of late neonatal deaths per year"
        },
        {
          "id": 3,
          "text": "Number of stillbirths over 1000 g per year"
        },
        {
          "id": 4,
          "text": "Number of early neonatal deaths per year"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Number of<strong> late neonatal deaths</strong> per year<strong> </strong>is not included in the perinatal mortality rate.</p>\n<p>The<strong> </strong>perinatal mortality rate (<strong>PMR</strong>) is calculated using the following parameters<strong> </strong>during a particular time period:</p>\n<ul>\n<li><strong>Late fetal</strong> <strong>deaths</strong> or stillbirths<strong> &gt;1000 g</strong><strong> </strong>- correlates to <strong>28 weeks</strong> of gestation</li>\n<li><strong>Early neonatal </strong>deaths<strong> </strong>- from birth to 7 days of life</li>\n<li><strong>Live births</strong> &gt;1000 g</li>\n</ul>\n<p>The neonatal mortality rate <strong>(NMR)</strong> refers to the rate of deaths within the <strong>first 28 days</strong> of life. It is calculated using the following parameters:</p>\n<ul>\n<li>Early neonatal deaths</li>\n<li>Late neonatal deaths - after 7<sup>th</sup> day but before 28<sup>th</sup> completed day of life</li>\n</ul><hr><h3>Related Pearl: Perinatal Mortality Rate</h3><ul>\n<li>The term &lsquo;perinatal mortality&rsquo; includes both<strong> late fetal death</strong> (stillbirths) and<strong> early neonatal deaths</strong>.</li>\n<li>Babies chosen for inclusion in perinatal statistics should be <strong>above a minimum birth weight</strong> (1000g at birth). If the birth weight is not available, a <strong>gestation period of at least 28 weeks</strong> should be used (as the weight at 28 weeks corresponds to 1000g). If both are not available, then <strong>crown to heel length of at least 35cm</strong> should be used.</li>\n<li>Generally, the <strong>PMR</strong> = Late fetal deaths and early neonatal deaths weighing over 1000g at birth x 1000/Total births(live+dead) weighing over 1000g at birth.</li>\n<li>The PMR is the yard-stick of obstetric and pediatric care before and around the time of birth.</li>\n<li>The PMR of India (2016) is 24 per 1000 births.</li>\n<li>The main causes of perinatal mortality are intrauterine and birth asphyxia, low birth weight, birth trauma, and intrauterine/neonatal infections.</li>\n</ul>\n<p>Please note that the <strong>actual perinatal period commences from the 22nd week of life, but at that time the fetus weighs only about 500g.</strong></p>\n<p>Therefore, <strong>only for statistical calculations and international comparisons, to calculate the perinatal mortality rate, the period from the 28th week</strong> of life is taken, as then the baby weighs about <strong>1000g</strong>. As mentioned, babies included in the perinatal <strong>statistics</strong> must weigh above <strong>1000g</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7034",
      "difficulty": "easy"
    },
    {
      "text": "Which disease is transmitted by the  following vector that is found in cracks and crevices of walls in the day time?",
      "choices": [
        {
          "id": 1,
          "text": "Japanese encephalitis"
        },
        {
          "id": 2,
          "text": "Visceral leishmaniasis"
        },
        {
          "id": 3,
          "text": "Dengue"
        },
        {
          "id": 4,
          "text": "Trypanosomiasis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given image is of a <strong>sandfly</strong>. It&nbsp;transmits <strong>visceral leishmaniasis</strong>.</p>\n<p>Note:<strong>&nbsp;Sandfly&nbsp;</strong>acts as a&nbsp;<strong>vector</strong>&nbsp;for the following diseases:</p>\n<ul>\n<li>Kala-azar</li>\n<li>Oriental sore</li>\n<li>Sandfly fever</li>\n<li>Oroya fever</li>\n</ul>\n<p><strong>Japanese encephalitis</strong>&nbsp;is transmitted by<strong>&nbsp;</strong>the<strong>&nbsp;Culex&nbsp;</strong>mosquito.&nbsp;<strong>Dengue</strong>&nbsp;is transmitted by the&nbsp;<strong>Aedes</strong>&nbsp;mosquito.</p>\n<p><strong>Trypanosomiasis</strong>&nbsp;is transmitted by&nbsp;the<strong>&nbsp;tsetse fly</strong>.</p><hr><h3>Related Pearl: Sandfly</h3><ul>\n<li>They are also referred to as <strong>Phlebotomus.</strong></li>\n<li>They transmit diseases such as <strong>kala-azar</strong> (visceral leishmaniasis), Oriental sore, sandfly fever, and Oroya fever.</li>\n<li>They are generally smaller than mosquitoes and are <strong>hairy insects.</strong></li>\n<li>They like to dwell in cracks and crevices in walls during the daytime. They are active during the night (<strong>nocturnal pests</strong>).</li>\n<li>They do not fly for more than <strong>50 yards.</strong></li>\n<li>They can be <strong>controlled by insecticides&nbsp;</strong>and also by proper sanitation.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e7a4a6340edf44ae8550e78a19029e0fx1280x864.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Arthropod- borne diseases</h3><table>\n<tbody>\n<tr>\n<td><strong>Arthropod</strong></td>\n<td><strong>Disease transmitted</strong></td>\n</tr>\n<tr>\n<td>Anopheles mosquito</td>\n<td>Malaria, Filariasis</td>\n</tr>\n<tr>\n<td>Culex mosquito</td>\n<td>Bancroftian filariasis, Japenese encephalitis, West nile fever, Viral arthritis</td>\n</tr>\n<tr>\n<td>Aedes mosquito</td>\n<td>Yellow fever, Dengue, Chikungunya, filariasis, zika</td>\n</tr>\n<tr>\n<td>Mansoni Mosquito</td>\n<td>Filariasis, Chikungunya</td>\n</tr>\n<tr>\n<td>Housefly</td>\n<td>Typhoid and paratyphoid fever, diarrhea, dysentery, cholera, gastroenteritis, amoebiasis, helminthic infestations, poliomyelitis, conjunctivitis, trachoma, anthrax, yaws, etc.</td>\n</tr>\n<tr>\n<td>Sandfly (Phlebotomus)</td>\n<td>Kala-azar(Visceral Leishmaniasis), oriental sore, Oroya fever, Sandfly fever</td>\n</tr>\n<tr>\n<td>Tsetse fly</td>\n<td>Sleeping sickness(African Trypanosomiasis)</td>\n</tr>\n<tr>\n<td>Louse</td>\n<td>Epidemic typhus, relapsing fever, trench fever, pediculosis</td>\n</tr>\n<tr>\n<td>Rat flea</td>\n<td>Bubonic plague, endemic typhus(Murine Typhus), hymenolepis diminuta</td>\n</tr>\n<tr>\n<td>Black fly(Simulium)</td>\n<td>Onchocerciasis</td>\n</tr>\n<tr>\n<td>Reduviid bug(Kissing bug/triatominae)</td>\n<td>Chagas disease(American Trypanosomiasis)</td>\n</tr>\n<tr>\n<td>Hard tick (Ixodes species)</td>\n<td>Tick typhus, viral encephalitis, viral fevers, viral hemorrhagic fever,(e.g. Kyasanur forest disease), tularemia, tick paralysis, human babesiosis, lyme disease</td>\n</tr>\n<tr>\n<td>Soft Tick (Argas species)</td>\n<td>Q fever, relapsing fever, Kyasanur forest disease (KFD) (can be casued by hard tick as well)</td>\n</tr>\n<tr>\n<td>Trombiculid mite</td>\n<td>Scrub typhus, Rickettsial pox</td>\n</tr>\n<tr>\n<td>Itch mites</td>\n<td>Scabies</td>\n</tr>\n<tr>\n<td>Cyclops</td>\n<td>Guinea-worm disease, fish tapeworm (D. latum)</td>\n</tr>\n<tr>\n<td>Cockroaches</td>\n<td>Enteric pathogens</td>\n</tr>\n<tr>\n<td>Sand flea (Tunga penetrance, Jiggar, Chigoe flea)</td>\n<td> Tungiasis, Ulcer in the feetnails</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/2906dd9502a9470fbf4d076e74e8e21a.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7915",
      "difficulty": "medium"
    },
    {
      "text": "A woman is planning a trip to Morocco, which is endemic for yellow fever. As per travel regulations, she receives the yellow fever vaccine. After how many days following vaccination is she eligible to travel?",
      "choices": [
        {
          "id": 1,
          "text": "5"
        },
        {
          "id": 2,
          "text": "10"
        },
        {
          "id": 3,
          "text": "15"
        },
        {
          "id": 4,
          "text": "7"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>This woman is eligible to travel to the endemic area <strong>10 days</strong> after being <strong>vaccinated</strong> for <strong>yellow fever</strong>. This period is required for the majority of vaccine recipients to <strong>develop immunity</strong>.</p>\n<p>The&nbsp;<strong>17D vaccine</strong>&nbsp;for yellow fever is given <strong>subcutaneously</strong>. Unvaccinated people are required to remain&nbsp;<strong>quarantined </strong>for<strong> 6 days&nbsp;</strong>(maximum period of incubation).</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8310",
      "difficulty": "medium"
    },
    {
      "text": "According to WHO recommendations, which of the following statements is incorrect with respect to handling vaccine diluents?",
      "choices": [
        {
          "id": 1,
          "text": "Vaccine diluent containing an active substance should not be frozen"
        },
        {
          "id": 2,
          "text": "Vaccine diluent cannot be replaced with distilled water for injection"
        },
        {
          "id": 3,
          "text": "Diluent used to reconstitute an oral vaccine can be injected"
        },
        {
          "id": 4,
          "text": "Vaccine diluent cannot be replaced with a different diluent to the one specified"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>According to the WHO recommendations, the <strong>diluent</strong> used to reconstitute an<strong> oral vaccine</strong> should <strong>never</strong> be <strong>injected</strong>. Diluents for oral vaccines tend to be of significantly large volumes per dose and are not formulated for injection. These diluents may not have sterility characteristics and constituents appropriate for sterile injection. To avoid serious injury to the recipient, neither oral vaccines nor their assigned diluents should ever be injected.</p>\n<p>WHO recommendations on handling vaccine diluents :</p>\n<ul>\n<li> Never reconstitute a vaccine with a different diluent to the one specified by the manufacturer.</li>\n<li> Never replace a vaccine diluent with water for injection</li>\n<li> Never inject an oral vaccine or a diluent used to reconstitute an oral vaccine   </li>\n<li> Never freeze a vaccine diluent containing an active substance </li>\n<li> Never use a reconstituted vaccine if foreign particulate matter is observed.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8494",
      "difficulty": "easy"
    },
    {
      "text": "Two patients presented to the tuberculosis OPD and were diagnosed with MDR-TB and XDR-TB, respectively. Both of them are resistant to which of the following drugs?<div class='question-desc-html'><ol>\n<li>Isoniazid</li>\n<li>Rifampicin&nbsp;</li>\n<li>One of Fluoroquinolones&nbsp;</li>\n<li>One of the second line injectables</li>\n<li>Linezolid/ Bedaquiline</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1 and 2"
        },
        {
          "id": 2,
          "text": "Only 2"
        },
        {
          "id": 3,
          "text": "1,2,3 and 4"
        },
        {
          "id": 4,
          "text": "Only 5"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Both the patients diagnosed with&nbsp;MDR-TB and XDR-TB are resistant to Isoniazid and Rifampicin.</p>\n<p><strong>Muti-drug resistant</strong>&nbsp;(MDR)&nbsp;<strong>tuberculosis</strong>&nbsp;(TB) shows resistance to&nbsp;<strong>isoniazid</strong>&nbsp;and&nbsp;<strong>rifampicin</strong>.&nbsp;</p>\n<p>MDR-TB poses a serious problem in the treatment of TB as isoniazid and rifampicin are the most potent first-line drugs.&nbsp;</p>\n<p>The treatment of MDR-TB is curated with drugs grouped into different classes by the world health organization (WHO).</p>\n<ul>\n<li>Group A: Levofloxacin, bedaquiline, linezolid</li>\n<li>Group B: Clofazimine, cycloserine</li>\n<li>Group C: Ethambutol, pyrazinamide, delamanid, ethionamide</li>\n</ul>\n<p>In patients treated previously or with additional drug resistance, a&nbsp;<strong>longer MDR-TB regimen</strong>&nbsp;of&nbsp;<strong>18-20 months</strong>&nbsp;is recommended. Drugs belonging to group A are preferred along with one drug from group B whenever possible. A&nbsp;<strong>shorter regimen</strong>&nbsp;of&nbsp;<strong>6 months</strong>&nbsp;including&nbsp;<strong>bedaquiline</strong>&nbsp;with other drugs can be used in patients not treated before and without extensive disease. In&nbsp;<strong>pregnant women</strong>&nbsp;with MRD-TB, drugs such as bedaquiline and delamanid should be avoided.&nbsp;</p>\n<p><strong>XDR-TB</strong>&nbsp;(<strong>extensively drug-resistant&nbsp;TB</strong>) is defined as&nbsp;<strong>multi-drug resistant&nbsp; TB</strong>&nbsp;(resistant to rifampicin and isoniazid) which is also<strong>&nbsp;</strong>resistant to one&nbsp;<strong>fluoroquinolone</strong>&nbsp;(eg. ofloxacin) AND&nbsp;resistant to at least <strong>one additional group A drug</strong> (as of 2021, these are<span>&nbsp;bedaquiline and linezolid)</span></p>\n<p>It is usually seen in patients who have previously received treatment for TB and have either failed to complete treatment or relapsed.</p><hr><h3>Related Pearl: ATT Regimen for TB Patients</h3><p>As per the latest recommendations from <strong>National Tuberculosis Elimination Programme (NTEP)</strong>, treatment of TB is now based primarily on <strong>drug susceptibility testing</strong>. This is irrespective of new cases, previously treated cases or recurrent TB cases. <br />All cases of TB are treated with Drug Sensitive TB Regimen, as long as the patient is sensitive to isoniazid and rifampicin. (<strong>No classification into category I or II</strong>)</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type of TB Case</strong></td>\n<td><strong>Intensive Phase</strong></td>\n<td><strong>Continuation Phase</strong></td>\n</tr>\n<tr>\n<td>New and previously treated cases (H and R sensitive)</td>\n<td>2 months H R Z E</td>\n<td>4 months H R E</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<h2><strong><span>Classification based on drug resistance. </span></strong></h2>\n<p><span>The<strong> </strong>cases are classified as:</span></p>\n<ul>\n<li><strong>Mono-resistant (MR):</strong> A TB patient, who is resistant to one 1st line anti-TB drug only.</li>\n<li><strong>Poly-Drug Resistant (PDR):</strong> A TB patient, who is resistant to more than one 1st line anti-TB drug, other than Rifampicin and isoniazid. </li>\n<li><strong>Rifampicin Resistant (RR):</strong> A TB patient, who is resistant to <strong>rifampicin</strong> with or without resistance to other drugs. Patients, who have rifampicin resistance, should be managed as if they are an MDR TB case.</li>\n<li><strong>Multi-Drug Resistant (MDR):</strong> A TB patient, who is resistant to <strong>both isoniazid and rifampicin.</strong></li>\n<li><strong>Extensively Drug-Resistant (XDR):</strong> A MDR TB patient who is additionally resistant to a <strong>fluoroquinolone</strong> (ofloxacin, levofloxacin, or moxifloxacin) and at least one additional group A drug (as of 2021, these are bedaquiline and linezolid)</li>\n</ul>\n<h2><strong><span>Standard DR TB regimen</span></strong></h2>\n<table>\n<tbody>\n<tr>\n<td><strong>Regimen class</strong></td>\n<td><strong>Drugs</strong></td>\n<td><strong>Comments</strong></td>\n</tr>\n<tr>\n<td><strong>H mono-resistant/ poly-drug resistant TB regimen</strong></td>\n<td>Lfx R E Z for 6 months</td>\n<td>\n<p>6 months long</p>\n<p>Oral drugs only</p>\n</td>\n</tr>\n<tr>\n<td><strong>BPaLM regime (New MDR regime by WHO)</strong></td>\n<td>Bdq Pa Lzd Mfx for 6 months</td>\n<td>\n<p>6 months long</p>\n</td>\n</tr>\n<tr>\n<td><strong>9- 11 months shorter oral bedaquiline regime (Shorter MDR)</strong></td>\n<td>\n<p><strong>Intensive Phase:</strong></p>\n<p>Lfx Bdq(6 months) Cfz Z Hh E Eto for 4-6 months</p>\n<p><strong>Continuation phase:</strong></p>\n<p>Lfx Cfz Z E for 5 months</p>\n</td>\n<td>\n<p>9-11 months long totally</p>\n<p>Injectables used in Intensive phase.</p>\n</td>\n</tr>\n<tr>\n<td><strong>Longer MDR TB regimen</strong></td>\n<td>Bdq(6 months or longer) Lfx Lzd Cfz Cs </td>\n<td>\n<p>18-20 months long</p>\n<p>Oral drugs only</p>\n<p>This regimen is used for XDR TB patients for 20 months.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<h2> </h2>\n<h2><strong><span>Criteria for patients to receive standard Drug Resistant TB regimen:</span></strong></h2>\n<table>\n<tbody>\n<tr>\n<td><strong>Standard Drug Resistant TB regimen</strong></td>\n<td><strong>Inclusion criteria</strong></td>\n<td><strong>Exclusion criteria</strong></td>\n</tr>\n<tr>\n<td><strong>H mono-resistant/poly-drug resistant TB regimen</strong></td>\n<td><strong>Isoniazid resistant</strong> TB with <strong>rifampicin sensitive</strong></td>\n<td>No specific criteria</td>\n</tr>\n<tr>\n<td><strong>BPaLM regimen (New MDR TB regimen by WHO)</strong></td>\n<td>\n<ol>\n<li><strong>MDR/RR-TB</strong> or <strong>pre-XDR-TB</strong> ( MDR/RR-TB and resistance to fluoroquinolones). </li>\n<li>Those with <strong>confirmed</strong> pulmonary TB and all forms of extrapulmonary TB (except for TB involving CNS, osteoarticular, and miliary TB).</li>\n<li>Patients <strong>&gt;14 years of age.<br /></strong></li>\n</ol>\n</td>\n<td>Pregnant and lactating women</td>\n</tr>\n<tr>\n<td><strong>9- 11 months shorter MDR TB regimen</strong></td>\n<td>Patient with <strong>rifampicin resistant</strong> pulmonary or extra pulmonary TB</td>\n<td>Non drug sensitivity test based criteria:\n<ul>\n<li>Pregnancy</li>\n<li>Any extra pulmonary disease in PLHIV</li>\n<li>Disseminated meningeal or central nervous system TB</li>\n<li>Intolerance to any drug in the shorter MDR TB regimen</li>\n</ul>\nDrug sensitivity test based criteria:\n<ul>\n<li>If DST/DRT result for FQ or SLI is resistant (XDR TB)</li>\n<li>Presence of InhA mutation</li>\n<li>Resistant to Z </li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Longer MDR TB regimen</strong></td>\n<td>Patients in whom <strong>shorter MDR TB regimen cannot be considered</strong> due to any reason</td>\n<td>None</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Legend</p>\n<p>FQ: Fluoroquinolone</p>\n<p>SLI: Second Line Injectable</p>\n<p>PLHIV: People Living with HIV</p>\n<p>Lfx: Levofloxacin</p>\n<p>Pa: Pretomanid</p>\n<p>H: Isoniazid</p>\n<p>Hh: High Dose Isoniazid</p>\n<p>R: Rifampicin</p>\n<p>E: Ethambutol</p>\n<p>Z: Pyrazinamide</p>\n<p>Mfx: Moxifloxacin</p>\n<p>Km: Kanamycin</p>\n<p>Am: Amikacin</p>\n<p>Eto: Ethionamide</p>\n<p>Cfz: Clofazimine</p>\n<p>Bdq: Bedaquiline</p>\n<p>Lzd: Linezolid</p>\n<p>Cs: Cycloserine</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF6545",
      "difficulty": "easy"
    },
    {
      "text": "Open vial policy is not applicable to which of the following vaccines?",
      "choices": [
        {
          "id": 1,
          "text": "Hepatitis B"
        },
        {
          "id": 2,
          "text": "BCG"
        },
        {
          "id": 3,
          "text": "Pentavalent vaccine"
        },
        {
          "id": 4,
          "text": "Rotoviral vaccine in New container"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Open vial policy</strong> is not applicable for BCG and measles vaccines.</p>\n<p>It is <strong>applicable</strong> for:</p>\n<ul>\n<li>DPT</li>\n<li>TT</li>\n<li><strong>Hepatitis B</strong> vaccine</li>\n<li><strong>OPV</strong></li>\n<li><strong>Pentavalent</strong> vaccine</li>\n<li>Rotavirus vaccine (New version with the VVM on the side)</li>\n</ul><hr><h3>Related Pearl: Open Vial Policy</h3><p>Open vial policy allows for reuse of partially used <strong>multidose vials</strong> of applicable vaccines under the Universal Immunization Programme in subsequent sessions up to&nbsp;<strong>4&nbsp;weeks</strong> subject to certain conditions and thereby reducing vaccine wastage.</p>\n<p>It is applicable only for <strong>DPT, TT, hepatitis B vaccine, OPV, liquid pentavalent vaccine, rotavirus vaccine(new version with the VVM on the side), and JE vaccines (inactivated). </strong>It is not applicable to <strong>BCG and measles vaccines.&nbsp;</strong></p>\n<p>Vaccine vials opened in session-site can be used in more than one session up to four weeks if <strong>expiry date has not passed, if storage and transport was appropriate, no contamination has occurred in vial septum, asepsis in withdrawing was practiced and if vaccine vial monitor has not reached discard point.</strong></p>\n<p>Open vials should <strong>not</strong> be submerged in water. All open vials should have a record of&nbsp;<strong>date and time of opening</strong>. At the end of a session, all vaccines should be returned to the cold chain point and segregated as re-usable and non-reusable. All open vials of BCG, measles must be destroyed after 48 hours or before next session, whichever is earlier.</p>\n<p>In case of any <strong>adverse events following immunization</strong>, all open vials should not be discarded until investigation is complete. All vials must be transported in zipper bags in the vaccine carrier and recorded in stock register. Ice packs used should be well sealed.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9477",
      "difficulty": "medium"
    },
    {
      "text": "All of the following are valid recommendations regarding wound care in cases of category III dog bites, except ______.",
      "choices": [
        {
          "id": 1,
          "text": "Wound should be thoroughly washed and dried followed by application of alcohol to the wound"
        },
        {
          "id": 2,
          "text": "If suturing is unavoidable, rabies immunoglobulin should be infiltrated in the depth and around the wound and suturing should be delayed by a few hours"
        },
        {
          "id": 3,
          "text": "In life threatening situations, minimal loose sutures maybe applied to arrest bleeding"
        },
        {
          "id": 4,
          "text": "Routine cauterization of wound should be performed wherever feasible to reduce incidence of nerve infection"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Wound cauterization</strong>&nbsp;is <strong>not recommended</strong> as it leaves a bad scar and does <strong>not confer any additional advantage</strong> over washing the wound with water and soap.</p>\n<p>The following<strong>&nbsp;measures</strong> should be<strong> taken immediately&nbsp;</strong>to <strong>stop </strong>the<strong> contraction</strong> of <strong>rabies</strong>:</p>\n<ul>\n<li><strong>Cleansing</strong> - The most important step in the prevention of rabies is <strong>washing</strong> the affected area with <strong>plenty </strong>of <strong>soap </strong>and<strong> water </strong>under a running tap for <strong>15 minutes</strong>. This is a standard procedure that minimizes the contraction of rabies.</li>\n<li><strong>Chemical treatment</strong> - Irrigation of the wound should then be done with virucidal agents like<strong> alcohol,&nbsp;tincture</strong>, 0.01% solution of aqueous&nbsp;iodine, or <strong>povidone-iodine</strong>. Even irrigating the wound with <strong>cetrimide + chlorhexidine</strong> solution can be done. This process eliminates the residual virus in the wound.</li>\n<li><strong>Suturing</strong> - <strong>Bite wounds</strong> are <strong>not sutured</strong> generally. If suturing is unavoidable, rabies immunoglobulin should be infiltrated in the depth and around the wound, and suturing should be delayed by a few hours.&nbsp;This delay in suturing allows the diffusion of antibodies in the tissues.</li>\n<li>In <strong>life-threatening situations</strong>, <strong>minimal loose sutures</strong>&nbsp;may be applied to <strong>arrest bleeding.</strong></li>\n<li><strong>Other measures</strong> - Local antibiotics and tetanus toxoid should be given.</li>\n</ul>\n<p>Different wound categories for post-exposure prophylaxis:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Categories of wound</strong></td>\n<td><strong>Post-exposure prophylaxis</strong></td>\n</tr>\n<tr>\n<td><strong>Category I</strong> - touching or feeding animals, licks on intact skin</td>\n<td>None</td>\n</tr>\n<tr>\n<td><strong>Category II</strong> - nibbling of uncovered skin, minor scratches, or abrasions <br />without bleeding</td>\n<td>Immediate vaccination and <br />local treatment of the wound</td>\n</tr>\n<tr>\n<td><strong>Category III</strong>- single or multiple transdermal bites or scratches, licks on broken skin&nbsp;contacts with bats</td>\n<td>Immediate vaccination and <br />administration of rabies <br />immunoglobulin; local <br />treatment of the wound</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Post-exposure prophylaxis regimen for rabies:</strong></p>\n<p><strong>Intramuscular regimen</strong>: In this regimen,&nbsp;1 ml or 0.5 ml of vaccine is injected into the deltoid in patients with category II and III wounds.</p>\n<ul>\n<li><strong>Essen regimen</strong>: It is a 5-dose regimen in which 1 dose of vaccine is given on days 0, 3, 7, 14, and 28 each.</li>\n<li><strong> Zagreb regimen</strong>: It is a 4-dose multisite regimen in which 2 doses of vaccine are given on day 0,&nbsp;followed by 1 dose on days 7 and 21 each.</li>\n</ul>\n<p><strong>Intradermal regimen</strong>: In this regimen, 0.1 ml of injection is given at 2 sites&nbsp;on days 0, 3, 7, and 28 each.</p><hr><h3>Related Pearl: Rabies vaccines and immunoglobulins schedules</h3><p>According to the Ministry of Health and Family Welfare, Government of India:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f49dfa01d9bd424db725e4ebf600cb98x1280x3397.JPEG\" alt=\"Pearl Image\"><p>WHO category <strong>II</strong> or <strong>III</strong> exposures should receive&nbsp;<strong>post-exposure prophylaxis&nbsp;</strong>(PEP)<strong>&nbsp;immediately.</strong></p>\n<p>One <strong>intradermal&nbsp;</strong>(ID)&nbsp;dose is <strong>0.1 mL</strong> of vaccine and one <strong>intramuscular</strong> (IM) dose is an <strong>entire vial</strong> of vaccine, irrespective of the vial size.</p>\n<p>Should a vaccine dose be delayed for any reason, the PEP schedule should be resumed (not restarted).</p>\n<p><strong>Rabies Immunoglobulin(RIG):&nbsp;</strong></p>\n<ul>\n<li>Passive immunization</li>\n<li><strong>Single-dose</strong>; after initiation of PEP and not beyond 7 days after the first dose of vaccine</li>\n<li>Max dose: <strong>hRIG - 20IU/kg ,&nbsp;</strong><strong>eRIG</strong><strong>&nbsp;- 40IU/kg </strong>body weight</li>\n<li>Vaccines should never be withheld regardless of the availability of RIG.</li>\n<li><strong>Alternatives</strong> for RIG- WHO recommends&nbsp;<strong>m</strong><strong>onoclonal antibodies&nbsp;</strong>(mAb)&nbsp;as a 'cocktail' containing at least <strong>two antibodies</strong> against the rabies virus.</li>\n</ul>\n<p>Administration of RIG:</p>\n<ul>\n<li>RIG should be administered&nbsp;<strong>into</strong> or <strong>around</strong> the <strong>wound site</strong> or sites.</li>\n<li>The&nbsp;<strong>remaining</strong> RIG, if any, should be injected <strong>IM</strong> at a site <strong>distant</strong> from the <strong>site</strong> of vaccine administration.</li>\n<li>RIG may be diluted to a volume sufficient for all wounds to be effectively and safely infiltrated.</li>\n</ul>\n<p>Prioritization&nbsp;of RIG allocation (numbered according to priority order):</p>\n<ol>\n<li>Multiple bites</li>\n<li>Deep wounds</li>\n<li>Bites to head, neck, and hands</li>\n<li>Patients with severe immunodeficiency</li>\n<li>Confirmed/probable rabies in biting animal</li>\n<li>Bites, scratches, and exposure of mucous membranes caused by a bat</li>\n</ol>\n<p><strong>Pre-exposure prophylaxis&nbsp;(PrEP)</strong></p>\n<p>PrEP is considered in the following conditions:</p>\n<ul>\n<li>High-risk groups- laboratory staff, wildlife wardens, veterinarians, animal handlers, and travelers to endemic regions.</li>\n<li>Remote, rabies-endemic areas where access to PEP is difficult</li>\n<li>Areas where&nbsp;dog bite incidence is &gt;5% per year</li>\n<li>Areas where vampire bat rabies is known to be present.</li>\n</ul>\n<p>Pre-exposure rabies vaccination consists of <strong>3&nbsp;intramuscular (IM) or 3 intradermal (ID)</strong>&nbsp;doses. These are given on <strong>days 0, 7 and 21 or 28.</strong></p>\n<ul>\n<li>Adults - the vaccine should always be administered in the deltoid area of the arm</li>\n<li>Young children (under 1 year of age)- Administration into the anterolateral area of the thigh is recommended.</li>\n<li><strong>Rabies vaccine </strong>should<strong> never</strong> be administered in the<strong> gluteal area.</strong>&nbsp;Administration in this manner will result in <strong>lower neutralizing antibody titers.</strong></li>\n</ul>\n<p>For exposed or re-exposed patients who can document previous completion of PEP or PrEP the following guidelines would be applicable:</p>\n<ul>\n<li>Proper wound management should be done.</li>\n<li>There is no need for the administration of RIG.</li>\n<li>One site ID or IM vaccine administration on days 0 and 3.</li>\n</ul>\n<p>Only adequate wound washing would be required in case of re-exposure where the animal bite victim has documented proof of complete PEP&nbsp;<strong>within the last three months.</strong></p>\n<p>The following cases are treated as fresh cases and given full PEP:</p>\n<ul>\n<li>Those who have previously received full post-exposure treatment with neural tissue vaccines (NTV) or vaccines of unproven potency</li>\n<li>Those who cannot document complete PEP or PrEP treatment&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF6104",
      "difficulty": "easy"
    },
    {
      "text": "In a school of 100 children, a child developed measles. Four days later, 3 of her classmates developed measles. What do these intervening four days correspond to?",
      "choices": [
        {
          "id": 1,
          "text": "Lead interval"
        },
        {
          "id": 2,
          "text": "Incubatory interval"
        },
        {
          "id": 3,
          "text": "Serial interval"
        },
        {
          "id": 4,
          "text": "Latent interval"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In the given scenario, the <strong>first child</strong> is the <strong>primary case</strong> and her <strong>classmates</strong> are the<strong> secondary cases</strong>. Hence, the <strong>interval between</strong> them developing the disease i.e., the intervening four days, is called the <strong>serial interval</strong>.</p>\n<p>The <strong>time</strong>&nbsp;<strong>interval</strong> between the onset of the <strong>primary case</strong> and the <strong>secondary case</strong> is called <strong>serial interval.</strong></p>\n<p>By collecting information about a whole series of such disease onsets, the distribution of the secondary cases can be made. From this information, an <strong>approximation</strong> of the <strong>incubation period</strong> can be done.</p>\n<p><strong>Lead time/lead interval</strong>&nbsp;refers to the period between the<strong> first possible </strong>time of<strong> detection</strong> and the <strong>usual time of diagnosis</strong>.</p>\n<p><strong>Incubatory interval/ incubation period </strong>refers to&nbsp;the time period between <strong>invasion</strong> of a<strong> pathogen</strong> to appearance of the <strong>first sign</strong> or <strong>symptom</strong>.</p>\n<p><strong>Latent interval/ latent period </strong>refers to&nbsp;the period between&nbsp;<strong>disease initiation</strong> to <strong>detection </strong>of the&nbsp;<strong>disease</strong>. It is usually used for non-infectious diseases and is equivalent to the incubation period.&nbsp;</p>\n<p>Note :</p>\n<ul>\n<li><strong>Primary case</strong>&nbsp;is the <strong>first</strong> case of a communicable disease <strong>introduced</strong> into a <strong>population</strong> unit. &nbsp;</li>\n<li><strong>Secondary case</strong> is one that develops after <strong>contact</strong> with the <strong>primary case</strong>.</li>\n<li><strong>Index case</strong> is the <strong>first </strong>case that comes to the <strong>notice</strong> of an <strong>investigator </strong>or&nbsp;physician.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6721",
      "difficulty": "medium"
    },
    {
      "text": "A group of researchers decided to conduct a study evaluating the relationship between thalidomide and fetal anomalies. The study design will be a case-control study. All of the following are advantages of case-control studies except:",
      "choices": [
        {
          "id": 1,
          "text": "Relatively quick and cost-effective"
        },
        {
          "id": 2,
          "text": "Minimal ethical problems"
        },
        {
          "id": 3,
          "text": "Suitable to investigate rare diseases"
        },
        {
          "id": 4,
          "text": "Relative risk is accurately calculated"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Relative risk</strong> can be calculated only in a <strong>cohort study</strong> and not in a case-control study.</p>\n<div class=\"page\" title=\"Page 94\">A <strong>case-control study</strong> or a <strong>retrospective study</strong> involves two populations- cases and controls. It progresses from effect to cause.</div>\n<div class=\"page\" title=\"Page 94\">&nbsp;</div>\n<div class=\"page\" title=\"Page 94\">Advantages of a case-control study:</div>\n<ul>\n<li>Relatively <strong>quick</strong> and <strong>cost-effective</strong></li>\n<li>Easy to carry out</li>\n<li><strong>Suitable to investigate rare diseases</strong></li>\n<li>Less risk to subjects</li>\n<li><strong>Minimal ethical problems</strong></li>\n<li>Relatively fewer subjects are required</li>\n</ul>\n<div class=\"page\" title=\"Page 94\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Relative risk refers to the ratio of the incidence of the disease among the exposed to the incidence of the disease among the non-exposed. It directly measures the strength of the association between the cause and the effect. Cohort studies provide a&nbsp;direct estimate of the relative risk since incidence can be calculated.&nbsp;</p>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Case Control Study</h3><p>In a <strong>case-control</strong> study, progression is from <strong>effect </strong>(disease) to<strong> cause</strong>&nbsp;(exposure) as the outcome or disease has already occurred. It is also called a&nbsp;<strong>retrospective</strong> study.</p>\n<p><strong>Design </strong>of case-control study:</p>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/54361314f5e0423d9bef0e4acae144a0x1280x1242.JPEG\" alt=\"Pearl Image\"><ul>\n<li><strong>Steps of case control study:</strong>\n<ul>\n<li>Selection of cases and controls</li>\n<li>Matching</li>\n<li>Measurement of exposure</li>\n<li>Analysis in the form of exposure rates, risk ratio, and odds ratio</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li><strong>Advantages of case control study:</strong>\n<ul>\n<li>Easy to carry out, rapid and inexpensive</li>\n<li>Requires few subjects, no risk to subjects</li>\n<li>Used to investigate rare diseases</li>\n<li>Different etiological factors can be studied and risk factors can be identified</li>\n<li>No attrition problems, minimal ethical problems</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li><strong>Disadvantages&nbsp;of case control study:</strong>\n<ul>\n<li>Relies on memory or past records giving rise to bias</li>\n<li>Selection of appropriate control groups is difficult</li>\n<li>Incidence cannot be measured</li>\n<li>Does not distinguish between causes and associated factors</li>\n<li>Not suited for evaluation of therapy or prophylaxis</li>\n<li>Representativeness of the cases and controls is often inadequate</li>\n</ul>\n</li>\n</ul><hr><h3>Related Pearl: Cohort Study</h3><ul>\n<li>A <strong>cohort study</strong> progresses from <strong>cause</strong> (exposure) <strong>to effect</strong> (disease).</li>\n<li>It is also known as <strong>forward-looking </strong>study, <strong>incidence </strong>study,<strong> prospective </strong>study, and<strong> longitudinal </strong>study.</li>\n<li><strong>Design of a cohort study:</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2ea236bdd083460eaa50179f47f0948dx1280x1373.JPEG\" alt=\"Pearl Image\"><ul>\n<ul>\n<li><strong>Types of cohort study:</strong>\n<ul>\n<li>Prospective (concurrent) cohort studies</li>\n<li>Retrospective (historical) cohort studies</li>\n<li>Combination cohort studies</li>\n</ul>\n</li>\n<li><strong>Steps of cohort study:</strong>\n<ul>\n<li>Selection of study subjects</li>\n<li>Obtaining data on exposure</li>\n<li>Selection of comparison groups</li>\n<li>Follow-up</li>\n<li>Analysis in terms of incidence rates and estimation of risk</li>\n</ul>\n</li>\n<li><strong>Advantages of cohort study:</strong>\n<ul>\n<li>Incidence can be calculated</li>\n<li>Several possible outcomes related to exposure can be studied at the same time</li>\n<li>Provides direct estimate of relative risk</li>\n<li>Calculation of dose-response ratio</li>\n<li>Minimization of certain biases</li>\n</ul>\n</li>\n<li><strong>Disadvantages of cohort study:</strong>\n<ul>\n<li>Cannot use for uncommon diseases</li>\n<li>Expensive, requires a large population and&nbsp;longer time</li>\n<li>Many common administrative and ethical problems</li>\n<li>High attrition and selection of subjects is difficult</li>\n<li>Dynamism of diagnostics is difficult to incorporate</li>\n<li>Tends to alter the behaviour of subjects known as&nbsp;<strong>Hawthorne effect</strong>.</li>\n</ul>\n</li>\n</ul>\n</ul><hr><h3>Related Pearl: Relative and Attributable Risk</h3><p>Relative Risk:</p>\n<ul>\n<li>Ratio of incidence of disease or death among exposed to that among the non-exposed is called <strong>relative risk (RR).</strong></li>\n<li>It is also called <strong>risk ratio</strong>.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f8f2d7bcf01a465699a42d1a750c87b8x1280x704.JPEG\" alt=\"Pearl Image\"><ul>\n<li>It is the direct measure of the <strong>strength of association</strong> between suspected cause and effect in <strong>cohort studies</strong>.</li>\n<li>RR &lt; 1 indicates inverse association(protective effect)</li>\n<li>RR = 1 indicates no association.</li>\n<li>RR &gt; 1 indicates positive association.</li>\n<li>RR of 2 indicates a 100% increase in risk.</li>\n<li>Relative risk calculation (RR) = [ a/(a+b) ]/ [ c/(c+d) ] where, </li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td> </td>\n<td colspan=\"3\">Cancer</td>\n</tr>\n<tr>\n<td rowspan=\"3\">Exposure</td>\n<td> </td>\n<td>yes</td>\n<td>no</td>\n</tr>\n<tr>\n<td>yes</td>\n<td>a</td>\n<td>b</td>\n</tr>\n<tr>\n<td>no</td>\n<td>c</td>\n<td>d</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n<p>Attributable Risk:</p>\n<ul>\n<li><strong>Attributable risk (AR)</strong> is the <strong>difference</strong> in incidence rates or proportions of disease or death between an exposed and non-exposed group.</li>\n<li>It is expressed in <strong>percentage</strong> and gives the extent to which the disease can be attributed to the exposure in a <strong>cohort study.</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c96f4beb9eb942899198d757d3388918x1280x904.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC8090",
      "difficulty": "easy"
    },
    {
      "text": "Surveillance data of an endemic disease reveals that most of the children in the area had been affected and had to be hospitalised. However, most of the adults remained asymptomatic carriers. Which category does this disease belong to?",
      "choices": [
        {
          "id": 1,
          "text": "Hyperendemic"
        },
        {
          "id": 2,
          "text": "Syndemic"
        },
        {
          "id": 3,
          "text": "Quasi-endemic"
        },
        {
          "id": 4,
          "text": "Holoendemic"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The disease in question belongs to the category of <strong>holoendemic diseases</strong>. In such diseases, a<strong> higher prevalence</strong> and pathogenic response are seen among&nbsp;the <strong>children</strong> in an area.&nbsp;The <strong>adults</strong> tend to be either&nbsp;<strong>asymptomatic carriers</strong> or show reduced damage by the disease process. E.g, malaria.</p>\n<p>An <strong>endemic</strong> disease is a disease that is <strong>present</strong> <strong>constantly</strong> in a population or in a given area without importation from outside. E.g, kala-azar in Bihar.</p>\n<p>A <strong>hyperendemic disease</strong> is a disease that is<strong> constantly</strong> present at <strong>high incidence</strong> and <strong>prevalence</strong> among all groups in a population. E.g, dengue in India.</p>\n<p>A <strong>syndemic</strong> is the <strong>aggregation</strong> of two or more<strong> concurrent</strong> or <strong>sequential</strong> <strong>epidemics</strong> or disease clusters in a population with biological interactions, which <strong>exacerbate</strong> the prognosis and <strong>burden of disease</strong>. It is also known as a&nbsp;<strong>synergistic epidemic</strong>.</p>\n<p>Note: Quasiendemic is not a term used in infectious disease epidemiology.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6516",
      "difficulty": "medium"
    },
    {
      "text": "A 3-week-old neonate presents to the outpatient for the first time. He was born by vaginal delivery at home and has not received any vaccines. Which of the following vaccines would be indicated at this visit, as per the National Immunization Schedule?",
      "choices": [
        {
          "id": 1,
          "text": "BCG vaccine"
        },
        {
          "id": 2,
          "text": "Hepatitis B vaccine"
        },
        {
          "id": 3,
          "text": "Oral polio vaccine-0"
        },
        {
          "id": 4,
          "text": "Injectable polio vaccine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>BCG (Bacille Calmette-Guerin)</strong>&nbsp;<strong>vaccine</strong> would be indicated in this <strong>3-week-old</strong> <strong>neonate</strong> at this visit as per the <strong>national immunization schedule</strong>.&nbsp;</p>\n<p>BCG is a<strong> live</strong> <strong>attenuated</strong> vaccine that can be given soon after <strong>birth</strong> until <strong>1 year</strong> of age. It&nbsp;is given <strong>intradermally&nbsp;</strong>at the <strong>left&nbsp;upper arm.</strong>&nbsp;It provides protection against the <strong>central nervous system</strong> and <strong>disseminated</strong>&nbsp;<strong>tuberculosis.</strong>&nbsp;The liquid (fresh) vaccine and the freeze-dried vaccine are the types available.&nbsp;<span data-preserver-spaces=\"true\">The WHO has recommended the&nbsp;</span><strong><span data-preserver-spaces=\"true\">Danish 1331</span></strong><span data-preserver-spaces=\"true\">&nbsp;strain for the production of the BCG vaccine.</span></p>\n<p>After 2-3 weeks of correct vaccine administration a <strong>papule</strong> develops at the site. Its size increases slowly and breaks into a <strong>shallow ulcer</strong> covered with a crust. Healing occurs within 6-12 weeks and will leave a <strong>permanent tiny round scar,&nbsp;</strong>which is a <strong>normal reaction</strong>. <strong>Adverse reactions</strong> seen with BCG vaccine administration are pain, swelling, redness,&nbsp;suppurative lymphadenitis, osteomyelitis, etc.&nbsp;</p>\n<p>The image below shows the BCG scar:&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c38a9db939eb47fb82f117f72c9d08c8x1280x2081.JPEG\" alt=\"Explanation Image\"><p><strong>Mission Indradhanush</strong> was launched to fully immunize children up to two years of age against <strong>seven vaccine-preventable diseases</strong> and pregnant women. The vaccines against the following diseases are included in this program <strong>diphtheria</strong>, <strong>pertussis</strong>, <strong>tetanus</strong>, <strong>tuberculosis</strong>, <strong>polio</strong>, <strong>hepatitis B</strong>, and <strong>measles</strong>. It was later modified to the <strong>intensified mission indradhanush&nbsp;</strong>to further strengthen the immunization coverage.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2847caa580874e3e94b01e559eaea49fx647x404.JPEG\" alt=\"Explanation Image\"><p>Other Options:</p>\n<p>Option B:&nbsp;<strong>Hepatitis B vaccine&nbsp;</strong>is a<strong> recombinant</strong> vaccine<strong>&nbsp;</strong>given at <strong>birth</strong>&nbsp;until the<strong> first 24 hours</strong>. It is&nbsp;given <strong>intramuscularly</strong> on the anterolateral&nbsp;side of the mid-thigh.&nbsp;</p>\n<p>Option C:&nbsp;<strong>Oral polio vaccine-0</strong> (OPV-0)&nbsp;<strong>&nbsp;</strong>is a <strong>live attenuated</strong> vaccine&nbsp;given at&nbsp;<strong>birth</strong> until<strong>&nbsp;</strong>the&nbsp;<strong>first 15 days.</strong></p>\n<p>Option D: <strong>Injectable polio vaccine </strong>(IPV) is a <strong>killed whole organism</strong> vaccine given at <strong>6</strong> and <strong>14 weeks</strong> of age.&nbsp;</p><hr><h3>Related Pearl: National Immunization Schedule (India)</h3><table>\n<tbody>\n<tr>\n<td><strong>Vaccine</strong></td>\n<td><strong>When to give</strong></td>\n<td><strong>Dose</strong></td>\n<td><strong>Route</strong></td>\n<td><strong>Site</strong></td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Pregnant Women</strong></td>\n</tr>\n<tr>\n<td>Td-1</td>\n<td>\n<p>Early in pregnancy</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td-2</td>\n<td>\n<p>4 weeks after Td-1*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td- Booster</td>\n<td>\n<p>If received 2 Td doses in a pregnancy <br />within the last 3 yrs*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Infants</strong></td>\n</tr>\n<tr>\n<td>BCG</td>\n<td>\n<p>At birth or as early as possible until one year of age</p>\n</td>\n<td>0.1 mL (0.05 mL until<br />1 month<br />age)</td>\n<td>Intra-dermal</td>\n<td>Left upper arm</td>\n</tr>\n<tr>\n<td>Hepatitis B - Birth Dose</td>\n<td>\n<p>At birth or as early as possible within 24 hrs</p>\n</td>\n<td>0.5 mL</td>\n<td> Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>OPV - 0</td>\n<td>\n<p>At birth or as early as possible within the first 15 days</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>OPV-1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until 5 years of age)</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>Pentavalent 1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>0.5 mL</td>\n<td>lntra·muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>Rotavirus</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>5 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>IPV</td>\n<td>\n<p>Two fractional doses at 6, 14 weeks </p>\n</td>\n<td>0.1 mL</td>\n<td>Intra-dermal two fractional dose</td>\n<td>Intra-dermal: right Upper arm (at 6, 14 weeks)<br /><br /></td>\n</tr>\n<tr>\n<td>\n<p>PCV</p>\n<p>(wherever applicable)</p>\n</td>\n<td>\n<p>At 6 weeks and 14 weeks; Booster at 9 completed months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra·muscular</td>\n<td>Antero-lateral side of mid-thigh, right</td>\n</tr>\n<tr>\n<td>Measles/MR 1<sup>st</sup> Dose</td>\n<td>\n<p>9 completed months to 12 months<br />(Can be given till 5 years of age)</p>\n</td>\n<td>0.5ml</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm</td>\n</tr>\n<tr>\n<td>JE- 1**</td>\n<td>\n<p>9 completed months to 12 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular(killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>\n<p>Anterolateral aspect of mid-thigh/Left upper arm </p>\n</td>\n</tr>\n<tr>\n<td>Vitamin A<br />(1st dose)</td>\n<td>\n<p>At 9 completed months with measles Rubella</p>\n</td>\n<td>1 mL (1 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Children </strong></td>\n</tr>\n<tr>\n<td>DPT booster-1</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh  </td>\n</tr>\n<tr>\n<td>Measles / MR 2<sup>nd </sup>dose</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm  </td>\n</tr>\n<tr>\n<td>OPV booster</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>JE-2</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular (killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>Anterolateral aspect of mid-thigh/Left upper arm </td>\n</tr>\n<tr>\n<td>Vitamin A***<br />(2nd to 9<sup>th</sup> dose)</td>\n<td>\n<p>16–18 months, followed by one dose every 6 months up to the age of 5 years</p>\n</td>\n<td>2 mL (2 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>DPT booster 2</td>\n<td>\n<p>5–6 years</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td</td>\n<td>10 years &amp; 16 years</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>\n<p>Upper arm</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*Give Td-2 or booster doses before 36 weeks of pregnancy. However, give these even if more than 36 weeks have passed. Give Td to a woman in labor, if she has not previously received Td.</p>\n<p>**JE vaccine is introduced in select endemic districts after the campaigns. Intramuscular (killed inactivated) vaccine is gradually replacing the live attenuated vaccine. This change is because the killed vaccines are more effective and require fewer doses.</p>\n<p>***The 2nd to 9th doses of vitamin A can be administered to children 1–5 years old during biannual rounds, in collaboration with ICDS.</p><hr><h3>Related Pearl: Types of Vaccines</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Type</strong></p>\n</td>\n<td>\n<p><strong>Vaccines</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Live attenuated</p>\n<p>(<strong>M</strong>ost<strong>&nbsp;</strong><strong>B</strong>eautiful&nbsp;<strong>P</strong>lace&nbsp;<strong>I</strong>n&nbsp;<strong>T</strong>he <strong>W</strong>orld<strong>&nbsp;</strong>-<strong> ROME)</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p><strong>M</strong>umps</p>\n<p><strong>B</strong>CG</p>\n<p><strong>P</strong>lague</p>\n<p><strong>I</strong>nfluenza (cold-adapted)</p>\n<p><strong>T</strong>yphoid (oral)</p>\n<p>Yello<strong>W&nbsp;</strong>fever</p>\n<p><strong>R</strong>ubella and&nbsp;<strong>R</strong>otavirus</p>\n<p><strong>O</strong>ral Polio (Sabin)</p>\n<p><strong>M</strong>easles</p>\n<p>Japanese&nbsp;<strong>E</strong>ncephalitis</p>\n<p>Varicella</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Killed whole organism</p>\n<p>(<strong>RIP</strong> <strong>ACE</strong>)</p>\n</td>\n<td>\n<p><strong>R</strong>abies</p>\n<p><strong>I</strong>nfluenza</p>\n<p><strong>P</strong>olio (IPV, Salk)</p>\n<p>Hep <strong>A</strong></p>\n<p><strong>C</strong>holera</p>\n<p><strong>E</strong>ncephalitis</p>\n<p>Typhoid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Toxoid/Protein</p>\n</td>\n<td>\n<p>Diphtheria</p>\n<p>Tetanus</p>\n<p>Acellular Pertussis</p>\n<p>Anthrax</p>\n<p>Influenza subunit&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Polysaccharide</p>\n</td>\n<td>\n<p>Pneumococcus</p>\n<p>Meningococcus</p>\n<p>Hemophilus influenza type b (Hib)</p>\n<p>Typhoid (Vi)&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>Glycoconjugate</p>\n</td>\n<td>\n<p>Hib</p>\n<p>Pneumococcus</p>\n<p>MenACWY(meningococcal vaccine)&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Recombinant</p>\n</td>\n<td>\n<p>Hepatitis B vaccine</p>\n<p>Lyme disease</p>\n<p>Cholera toxin B</p>\n<p>HPV&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Open Vial Policy</h3><p>Open vial policy allows for reuse of partially used <strong>multidose vials</strong> of applicable vaccines under the Universal Immunization Programme in subsequent sessions up to&nbsp;<strong>4&nbsp;weeks</strong> subject to certain conditions and thereby reducing vaccine wastage.</p>\n<p>It is applicable only for <strong>DPT, TT, hepatitis B vaccine, OPV, liquid pentavalent vaccine, rotavirus vaccine(new version with the VVM on the side), and JE vaccines (inactivated). </strong>It is not applicable to <strong>BCG and measles vaccines.&nbsp;</strong></p>\n<p>Vaccine vials opened in session-site can be used in more than one session up to four weeks if <strong>expiry date has not passed, if storage and transport was appropriate, no contamination has occurred in vial septum, asepsis in withdrawing was practiced and if vaccine vial monitor has not reached discard point.</strong></p>\n<p>Open vials should <strong>not</strong> be submerged in water. All open vials should have a record of&nbsp;<strong>date and time of opening</strong>. At the end of a session, all vaccines should be returned to the cold chain point and segregated as re-usable and non-reusable. All open vials of BCG, measles must be destroyed after 48 hours or before next session, whichever is earlier.</p>\n<p>In case of any <strong>adverse events following immunization</strong>, all open vials should not be discarded until investigation is complete. All vials must be transported in zipper bags in the vaccine carrier and recorded in stock register. Ice packs used should be well sealed.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD1448",
      "difficulty": "easy"
    },
    {
      "text": "In the syndromic management of sexually transmitted infections, the grey kit consists of __________",
      "choices": [
        {
          "id": 1,
          "text": "T.Azithromycin + T.Doxycycline"
        },
        {
          "id": 2,
          "text": "T.Secnidazole + C.Fluconazole"
        },
        {
          "id": 3,
          "text": "T.Azithromycin + T.Cefixime"
        },
        {
          "id": 4,
          "text": "T.Acyclovir"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In the syndromic management of sexually transmitted infections, the <strong>grey kit</strong> consists of&nbsp;<strong>T.Azithromycin and T.Cefixime</strong></p>\n<p>The color coded packs are as follows:</p>\n<ul>\n<li><strong>Kit 1</strong>&ndash; Grey, for urethra discharge, anorectal discharge, and cervicitis.</li>\n<li><strong>Kit 2</strong>&ndash; Green, for vaginitis</li>\n<li><strong>Kit 3</strong>&ndash; White, for genital ulcers</li>\n<li><strong>Kit 4</strong>&ndash; Blue, for genital ulcers.</li>\n<li><strong>Kit 5</strong>&ndash; Red, for genital ulcers.</li>\n<li><strong>Kit 6</strong>&ndash; Yellow, for lower abdominal pain</li>\n<li><strong>Kit 7</strong>&ndash; Black, for inguinal bubo</li>\n</ul><hr><h3>Related Pearl: Syndromic Management of Sexually Transmitted Infections</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1167210a9cd6434a905a98bc64668d41x1280x2612.PNG\" alt=\"Pearl Image\"><p>Partner Management when <strong>asymptomatic</strong> is not required for <strong>Gardenella vaginalis, Candida and Herpes infections</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/60da7b1257d04ca5938ef3340533e6b9x1280x2974.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD2305",
      "difficulty": "medium"
    },
    {
      "text": "A sexually active woman who was using barrier contraceptives is planning on switching to DMPA injectables. Which of the following is the correct dosage of this contraceptive?",
      "choices": [
        {
          "id": 1,
          "text": "200 mg every 3 months"
        },
        {
          "id": 2,
          "text": "250 mg every 2 months"
        },
        {
          "id": 3,
          "text": "100 mg every 2 month"
        },
        {
          "id": 4,
          "text": "150 mg every 3 months"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The dosage for <strong>injectable&nbsp;</strong>depot-medroxyprogesterone acetate (<strong>DMPA</strong>) is <strong>150 mg every 3 months.</strong></p>\n<p>It <strong>acts by:</strong></p>\n<ul>\n<li>Bringing changes in the cervical mucus</li>\n<li>Making the endometrium hostile</li>\n<li>Preventing ovulation</li>\n</ul>\n<p><strong>Disadvantages</strong> include <strong>spotting</strong> and <strong>intermediate</strong>&nbsp;per vaginal&nbsp;<strong>bleeding</strong>.</p><p><strong>Antara</strong>&nbsp;(Injectable contraceptive DMPA) and <strong>Chhaya</strong> (oral contraceptive Centchroman) were launched by the Government under its <strong>Mission Parivar Vikas.&nbsp;</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/86bd1bc1e387428a871ff147a72ba92dx398x265.PNG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/de9fec57e05b490e86a15552c7c8a07dx432x273.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8238",
      "difficulty": "easy"
    },
    {
      "text": "According to the National Framework for Malaria Elimination in India, states are classified based on which of the following parameters?",
      "choices": [
        {
          "id": 1,
          "text": "Annual parasite incidence"
        },
        {
          "id": 2,
          "text": "Slide positivity rate"
        },
        {
          "id": 3,
          "text": "Annual falciparum incidence"
        },
        {
          "id": 4,
          "text": "Annual blood examination rate"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong>annual parasite incidence (API)</strong>&nbsp;is used in classifying states/UTs according to the National Framework for Malaria Elimination in India.&nbsp;</p>\n<p>The Annual Parasite Incidence&nbsp;is calculated as: (Cases in one year &times;1000) / (Population under surveillance).</p><hr><h3>Related Pearl: Malaria in the National Vector Borne Disease Control Programme (NVBDCP)</h3><p><strong>National Framework for Malaria Elimination in India (2016-2030)</strong></p>\n<ul>\n<li><strong>Goals:</strong> To eliminate malaria and maintain malaria-free status.</li>\n<li><strong>Objectives:</strong>\n<ul>\n<li>By 2022, transmission of malaria interrupted and zero indigenous cases.</li>\n<li>By 2024, incidence of malaria to be reduced to &lt;1 case per 1000 population.</li>\n<li>By 2030, malaria to be eliminated throughout the country.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Classification of states/UTs according to the Annual Parasite Index (API):</strong></p>\n<p>&nbsp;</p><table>\n<tbody>\n<tr>\n<td><strong>Category</strong>&nbsp;</td>\n<td><strong>Criteria&nbsp;</strong></td>\n<td><strong>Major measures:</strong></td>\n</tr>\n<tr>\n<td>Category 0&nbsp;</td>\n<td>States/UTs with zero indigenous cases&nbsp;</td>\n<td>Detect re-introduced cases and notify and maintain malaria-free status.&nbsp;</td>\n</tr>\n<tr>\n<td>Category 1&nbsp;</td>\n<td><strong>Elimination phase &ndash;</strong> States/UTs with API &lt;1 and all their districts reporting API &lt;1&nbsp;</td>\n<td>Interruption of local transmission.</td>\n</tr>\n<tr>\n<td>Category 2&nbsp;</td>\n<td><strong>Pre-elimination phase &ndash;</strong> States/UTs with API &lt;1 but some districts reporting API&nbsp;&ge;1.&nbsp;</td>\n<td>\n<p>Screening.&nbsp;</p>\n<p>Setting up one-stop mobile centres/clinics.&nbsp;</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Category 3&nbsp;</td>\n<td><strong>Intensified control phase &ndash;</strong> States/UTs with API&nbsp;&ge;1.&nbsp;</td>\n<td>&nbsp;Same as category 2</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<ul>\n<li>The <strong>National Strategic Plan (NSP) for Malaria Elimination&nbsp;</strong>(2017-22) was launched by the Ministry of Health and Family Welfare under NVBDCP, which is based on the <strong>National Framework for Malaria Elimination </strong>(2016 &ndash; 2030).</li>\n<li>The <strong>NSP</strong> focuses mainly on the <strong>districts</strong> which function as the <strong>operational units.</strong></li>\n</ul>\n<p>Accordingly, all the districts are classified into the following <strong>four</strong> categories:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Category of districts</strong></td>\n<td><strong>Definition</strong></td>\n</tr>\n<tr>\n<td><strong>Category 0</strong>: Prevention of re-establishment phase</td>\n<td>&nbsp;Includes all districts in which no incidence of malaria was reported in the last 3 years.</td>\n</tr>\n<tr>\n<td><strong>Category 1:</strong> Elimination phase</td>\n<td>&nbsp;Districts with API &lt;1 per 1000 population.</td>\n</tr>\n<tr>\n<td><strong>Category 2: </strong>Pre elimination phase</td>\n<td>&nbsp;Districts with API in between 1-2 per 1000 population.</td>\n</tr>\n<tr>\n<td><strong>Category 3:</strong> Intensified control phase</td>\n<td>&nbsp;Districts with API &gt;2 per 1000 population.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>The above classification is more operational than the classification mentioned in the <strong>NFME</strong> which is <strong>state</strong> focussed.</p>\n<p>The goal of&nbsp;<strong>NSP strategy </strong>is the phased elimination of malaria in India. The National Framework for Malaria Elimination (<strong>NFME</strong>) in India has set <strong>2030</strong> as the goal for eliminating malaria, and the goals of NSP in consonance with overall goals.</p>\n<p><strong>The goals of NSP 2017 &ndash; 2022 are:</strong></p>\n<ul>\n<li>Eliminate malaria in <strong>category 1</strong> (API &lt; 1) districts by <strong>2020</strong>, and <strong>category 2</strong> (API 1-2) districts by <strong>2022</strong>.</li>\n<li>Reduce transmission in <strong>category 3</strong> districts to stabilize API at&nbsp;<strong>&lt;1 </strong>by <strong>2022</strong>.</li>\n</ul>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7938",
      "difficulty": "easy"
    },
    {
      "text": "The following table shows the comparison of results between a screening test and a diagnostic test for HIV infection. Choose the correct option.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td>ELISA result</td>\n<td>&nbsp;PCR Positive</td>\n<td>PCR Negative</td>\n<td>Total&nbsp;</td>\n</tr>\n<tr>\n<td>Positive</td>\n<td>80</td>\n<td>30</td>\n<td>110</td>\n</tr>\n<tr>\n<td>Negative&nbsp;</td>\n<td>20</td>\n<td>70</td>\n<td>90</td>\n</tr>\n<tr>\n<td>Total&nbsp;</td>\n<td>100</td>\n<td>100</td>\n<td>200</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "The specificity of the screening test is 90%"
        },
        {
          "id": 2,
          "text": "The sensitivity of the screening test is 80%"
        },
        {
          "id": 3,
          "text": "The specificity of the screening test is 80%"
        },
        {
          "id": 4,
          "text": "The sensitivity of the screening test  is 90%"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In HIV infection, the screening test is ELISA and diagnostic test is PCR. The sensitivity of the screening test (ELISA) is <strong>80%.&nbsp;&nbsp;</strong></p>\n<table>\n<tbody>\n<tr>\n<td>ELISA result</td>\n<td>&nbsp;PCR Positive</td>\n<td>PCR Negative</td>\n<td>Total&nbsp;</td>\n</tr>\n<tr>\n<td>Positive</td>\n<td>80(a)</td>\n<td>30(b)</td>\n<td>110</td>\n</tr>\n<tr>\n<td>Negative&nbsp;</td>\n<td>20(c)</td>\n<td>70(d)</td>\n<td>90</td>\n</tr>\n<tr>\n<td>Total&nbsp;</td>\n<td>100</td>\n<td>100</td>\n<td>200</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<ul>\n<li>&nbsp;Sensitivity = a/a+c = 80/80+20 = 80%</li>\n<li>&nbsp;Specificity = d/d+b = 70/70+30 = 70%</li>\n<li>&nbsp;Positive predictive value = a/a+b = 80 / 80+30 = 72.7%</li>\n<li>&nbsp;Negative predictive value = d/d+c = 70 / 70+20 = 77.7%</li>\n</ul><hr><h3>Related Pearl: Validity of a Screening Test</h3><ul>\n<li><strong>Validity/ accuracy </strong>of a screening test depends upon the <strong>sensitivity, specificity,</strong> and<strong> predictive accuracy</strong> of the test.</li>\n<li>It represents the closeness to a true value/ actual value.</li>\n<li>These are the <strong>inherent properties</strong> of a screening test.</li>\n<li>P<strong>P</strong>V and N<strong>P</strong>V are <strong>dependent</strong> on the <strong>P</strong>revalence of disease.</li>\n<li>Sensitivity &amp; Specificity are independent of prevalence of disease.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/62275b1d441443bc92db11bb3add523ex1280x959.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Formulae</strong>&nbsp;</td>\n</tr>\n<tr>\n<td><span>Sensitivity</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;<strong>TP</strong>&nbsp; &nbsp;&nbsp;</span></span><br /><span><strong>TP</strong> + FN</span></td>\n</tr>\n<tr>\n<td><span>Specificity</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;<strong>TN&nbsp; &nbsp;&nbsp;</strong></span><sub><br /></sub>FP + <strong>TN</strong></span></td>\n</tr>\n<tr>\n<td><span>Predictive value of a positive test (<strong>P</strong>PV)</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;T<strong>P&nbsp; &nbsp;&nbsp;</strong></span><sub><br /></sub>T<strong>P</strong> + F<strong>P</strong></span></td>\n</tr>\n<tr>\n<td><span>Predictive value of a negative test (<strong>N</strong>PV)</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;T<strong>N&nbsp; &nbsp;&nbsp;</strong>&nbsp;</span><sub><br /></sub>T<strong>N</strong> + F<strong>N</strong></span></td>\n</tr>\n<tr>\n<td><span>Percentage of false positives</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;FP&nbsp; &nbsp; &nbsp;</span><sub><br /></sub>FP + TN</span></td>\n</tr>\n<tr>\n<td><span>Percentage of false negatives</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;FN&nbsp; &nbsp; &nbsp;</span><sub><br /></sub>TP + FN</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li><strong>PPV</strong> varies <strong>directly</strong> with prevalence</li>\n<li><strong>NPV</strong> varies <strong>inversely</strong> with prevalence</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8473",
      "difficulty": "easy"
    },
    {
      "text": "All of the following modalities are mass approaches for communication, except _______.",
      "choices": [
        {
          "id": 1,
          "text": "Posters"
        },
        {
          "id": 2,
          "text": "Role play"
        },
        {
          "id": 3,
          "text": "Folk methods"
        },
        {
          "id": 4,
          "text": "Newspaper"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Role play</strong>&nbsp;is the <strong>dramatization</strong> of social situations for health education by those taking part in it. It is a <strong>group approach</strong> of communication.</p>\n<p>A <strong>workshop</strong> is a series of <strong>meetings </strong>with an emphasis on <strong>individual work</strong> within the group. External consultants or experts may be involved.</p>\n<p>A <strong>symposium</strong> is a series of <strong>lectures</strong> on a selected subject by experts after which the audience is allowed to ask questions (no discussion is involved).</p>\n<p><strong>Seminars </strong>are similar to conferences and incorporate a variety of methods like speeches, discussions for health education, which may last for half a day to a week.</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"3\">Methods of Health Communication&nbsp;&nbsp;&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Individual approach</strong></td>\n<td><strong>Group approach</strong></td>\n<td><strong>Mass approach</strong></td>\n</tr>\n<tr>\n<td>\n<ol>\n<li>Personal contact</li>\n<li>Home visits</li>\n<li>Personal letters</li>\n</ol>\n</td>\n<td>\n<ol>\n<li>Lectures</li>\n<li>Demonstrations</li>\n<li>Discussion methods\n<ul>\n<li>Group discussions</li>\n<li>Panel discussion</li>\n<li>Symposium</li>\n<li>Workshop</li>\n<li>Conferences</li>\n<li>Seminars</li>\n<li>Role play</li>\n</ul>\n</li>\n</ol>\n</td>\n<td>\n<ol>\n<li>TV</li>\n<li>Radio</li>\n<li>Newspaper</li>\n<li>Printed material</li>\n<li>Direct mailing</li>\n<li>Posters</li>\n<li>Health museums</li>\n<li>Health exhibitions</li>\n<li>Folk method</li>\n<li>Internet</li>\n</ol>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF6562",
      "difficulty": "medium"
    },
    {
      "text": "Which of these is the correct formula to calculate Quetelet’s index?",
      "choices": [
        {
          "id": 1,
          "text": "Weight in kg / Square of height in meters"
        },
        {
          "id": 2,
          "text": "Square of weight in kg/Height in meters"
        },
        {
          "id": 3,
          "text": "Weight in grams/square of height in meters"
        },
        {
          "id": 4,
          "text": "Square of weight in kg/Height in centimeters"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Quetelet&rsquo;s</strong> index or body mass index <strong>(BMI)</strong> is calculated by <strong>weight in kg/square of height in meters</strong>. It is a method of assessing obesity.</p><hr><h3>Related Pearl: Indicators for Body fat</h3><p><strong>The indicators for body fat are:</strong></p>\n<p><strong>Body weight</strong>: +3SD (standard deviations) from the median weight for height as a cut-off point for obesity. For adults, some people calculate various other indicators such as:</p>\n<ul>\n<li><strong>Body mass index (Quetelet's index)</strong>: Weight (kg) / Square of height in metres</li>\n<li><strong>Ponderal index</strong>: Weight (kg)/Height^3 (m)</li>\n<li>Corpulence index: Actual weight /desirable weight.(Should not exceed 1.2)</li>\n</ul>\n<p><strong>Broca's index</strong> = Height (cm) - 100 . </p>\n<p><strong>Lorentz's formula</strong> <br />Ht (cm) - 100 - [ (Ht (cm) - 150) / 2 for women or 4 for men ]</p>\n<p><strong>Skinfold thickness:</strong> Four sites mid-triceps, biceps, subscapular and suprailiac regions. The sum of the measurements should be less than 40 mm in boys and 50 mm in girls.</p>\n<p><strong>Waist circumference and waist-hip ratio</strong>: At the mid point between the lower border of the rib cage and the iliac crest. There is an increased risk of metabolic complications for men with a waist circumference~ 102 cm, and women with a waist circumference~ 88 cm. A high WHR (&gt; 1.0 in men and&gt; 0.85 in women) indicates abdominal fat accumulation.</p>\n<p><strong>Total body water</strong></p>\n<p><strong>Total body potassium</strong></p>\n<p><strong>Body density </strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD1462",
      "difficulty": "easy"
    },
    {
      "text": "In order to effectively prevent endemic goiter, what is the recommended iodine content in salt at the consumer level?",
      "choices": [
        {
          "id": 1,
          "text": "10 ppm"
        },
        {
          "id": 2,
          "text": "15 ppm"
        },
        {
          "id": 3,
          "text": "20 ppm"
        },
        {
          "id": 4,
          "text": "30 ppm"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The recommended level of iodine content in salt&nbsp;is <strong>15 ppm</strong> at the&nbsp;<strong>consumer</strong> <strong>level</strong> and <strong>30 ppm&nbsp;</strong>at the&nbsp;<strong>production</strong>&nbsp;<strong>level</strong>.</p>\n<p>The iodization of salt is used as a <strong>prophylactic</strong> measure against <strong>endemic goiter</strong>. In India, the level of iodization is fixed under the Prevention of Food Adulteration (PFA) Act.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8152",
      "difficulty": "easy"
    }
  ]
}